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ABSTRACT
GENETIC VARIATION IN POTENTIALLY VIRULENT VIBRIO
PARAHAEMOLYTICUS FROM THE NORTHERN GULF OF MEXICO
By Nicholas Felix Noriea III
May 2012
Vibrio parahaemolyticus (Vp) is a gram-negative bacterium found naturally in
marine and estuarine environments. Vp is found in oysters including those which are later
consumed by the public. Sub-populations of potentially virulent Vp contain specific
virulence factors and are relevant human pathogens capable of causing gastroenteritis,
wound infection, and death. The tdh and trh genes, both encoding hemolysins, have been
correlated with the majority of clinical Vp isolates but have not been shown to be the
definitive virulence factors.
A total of 146 Vp isolates from the northern Gulf of Mexico were collected and
probed for the presence of specific virulence factors such as tdh, trh, Type III secretion
System (T3SS) 1, T3SS2α, T3SS2β, and toxRS. The most representative sub-group of
potentially pathogenic Vp were tdh+/trh+. Isolates containing only tdh were uncommon,
and tdh-/trh+ isolates were extremely rare.
The distribution of virulence factors in environmental Vp strains was compared
with strain fitness through Vp human intestinal epithelial cell cytotoxicity assays and
oyster (Crassostrea virginica) hemocyte bactericidal challenges. The assays were
performed to determine significant differences in cytotoxicity or bactericidal survival
between pathogen subgroups (tdh+/trh-, tdh-/trh+, and tdh-/trh+).
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Significant changes in Vp gene expression were measured for representative
clinical strains of the diametric virulence factor sub-groups tdh+/trh- and tdh-/trh+.
Transcriptomic changes were measured during exposure to human intestinal epithelial cells
and oyster hemocyte. Relative changes in the Vp transcriptome were compared both over
time and between strain to give significantly regulated genes involved in cytotoxicity and
oyster hemocyte bactericidal avoidance.
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CHAPTER I
INTRODUCTION
Vibrio parahaemolyticus (Vp) is a gram-negative, facultatively anaerobic motile
rod-shaped bacterium. Vp was originally described in 1954 (1) after it was isolated as the
causative agent of “summer diarrhea” in Japan. Due to its halophilic nature, Vp is
ubiquitous in marine and coastal environments (2, 3). A characteristic member of the
Gammaproteobacteria, Vp is both ecologically and medically important (4-6), affecting
local and regional human populations including those in the northern Gulf of Mexico.
Vp is present in both the sediment and the water column (7) with cell densities
showing significant correlation to temperature and, to a lesser extent, salinity (Johnson et
al in prep)(7). Aquatic organisms can also act as a biological reservoir for these bacteria.
Vp can accumulate in filter-feeding molluscs, including oysters in densities of over 100
times that in surrounding waters (8); Vp is also found in the hemolymph of blue crabs (9,
10), in shrimp homogenate (11), and on copepods (4, 12).
Vp densities may be in high enough to cause illness in humans when oysters and
other seafood are eaten raw or under-cooked. The FDA estimates the infective dose to be
1x106 colony forming units (cfu) (13).Virulent Vp can cause gastroenteritis, wound
infections, and septicemia (14-17). Although the first recorded evidence of Vp-induced
disease was in 1954, outbreaks out Vp are reported worldwide today (18-21), especially in
countries where large amounts of seafood are consumed. It has been estimated that there
are as many as 4,500 cases of Vp infections per year in the US, with 30 hospitalizations
and 1-2 deaths (22). Although outbreaks of disease-causing Vp are not rare, potentially
virulent Vp represent a minor subpopulation (<10%) of the overall Vibrio community in
most aquatic environments (7, 23-25).
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In 1969, clinical Vp isolates were tested on a newly developed specialized blood
agar called Wagatsuma agar (3). Japanese scientists observed that some Vp strains
exhibited hemolysis on Wagatsuma agar. The occurrence of this β –hemolysis was coined
the “Kanagawa phenomenon” (KP) and was correlated with clinical strains (3).
Specifically, Vp isolates from 128 dysentery patients and 308 patients with food-poisoning
were plated onto Wagatsuma agar where β –hemolysis was observed in 95.3% and 88.3%
of strains, respectively (3). In 1980, KP was shown to be caused by a novel hemolysin,
Thermostable Direct Hemolysin (TDH), encoded by the tdh gene (26). In 1988, a second
hemolysin was identified in a tdh- KP- clinical strain. The second hemolysin had
extremely similar immunological characteristics to TDH, except that it was heat labile
unlike TDH; it was named the TDH-related hemolysin (TRH) (27). Like TDH, TRH
contains two subunits and the amino acid sequences encoding both hemolysins shares
roughly 67% homology.
In multiple studies over several years, 90% of 784 clinical Vp isolates were found
to contain either tdh, trh, or both (3, 28, 29), while similar studies found less than 1% of
environmental isolates carried either gene (3, 30). A recent study done in coastal
Mississippi found that between 4-5% of total environmental isolates carried either tdh or
trh (31). The presence of both tdh and trh production has been correlated with human
pathogenic Vp; therefore strains containing tdh and/or trh are considered ‘potentially
pathogenic’. Each hemolysin has been associated with pathogenicity in varying degrees.
One study of 214 clinical strains showed that 52.3% were tdh+/trh- , while 24.3% were tdh/trh+ (29). Another study in Calcutta, India observed that 90% of isolates taken from
clinical patients were tdh+/trh- compared to just 0.8% for tdh-/trh+ strains (32). A study in
Thailand found 76% of 317 clinical specimens to be tdh+/trh- (33).
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It should be noted that tdh and trh are not present in all clinical strains (34) and
therefore do not fully account for Vp pathogenicity or virulence (35). Studies of a tdhdeleted Vp strain revealed that even without TDH production, effects of cytotoxicity and
enterotoxicity were still observed, although in reduced amounts (36, 37). As mentioned
earlier, roughly 10% of 784 clinical isolates from several studies did not contain either the
tdh or the trh gene. In 1990, an experiment was performed which examined the virulence
of both tdh+ and tdh- Vp isolates in mice (38). The calculated LD50 was found to be 107
and 108 for each isolate, respectively. These findings led the researchers to conclude that
although tdh+ isolates were found predominantly in human clinical cases, lethality between
tdh and trh in mice remained equal. Therefore, other factors must be responsible for the
overall enteropathogenic affects of Vp.
Vp has several distinct pandemic serotypes. Vp is typed by the presence of O
antigen (the lipid moiety outer membrane lipopolysaccharide) and K antigen. Prior to
1996, isolates from international clinical cases displayed a wide range of these antigens.
Due to the varied nature of these serogroups, no true Vp pandemic serotype was identified.
In a study of 86 clinical Vp isolates obtained in Japan and Thailand between 1962 and
1999, it was shown that before 1996 there was no predominant clinical strain of (39). One
exception was observed in a study of clinical isolates originating in the United States from
1979 to 1987. In this study the majority of infections (71%) were shown to be urease
positive. Of the urease positive isolates, 59% were associated with a single serovar,
O4:K12 (40). All O4:K12 isolates in this study were urease positive. This was the first
major report of a pandemic-like Vp serovar with an associated atypical virulence factor,
urease.
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A study in Calcutta, India monitored hospitalized patients for a period of several
years, and in February of 1996 a rapid and distinct change to the antigenic pattern in
clinical strains of Vp was seen (32). A single predominant serovar, O3:K6 (32, 39), was
observed in ~65% of all cases in 1996 but not in the initial two years of observation. This
O3:K6 strain was different from previously isolated O3:K6 strains as it contained tdh but
not trh (41), and thus was termed the ‘new’ O3:K6. Interestingly, the new O3:K6 serovar
had not been isolated previously to February of 1996, leading scientists to conclude that
this O3:K6 serovar was a unique novel clone (32). During a high-incidence period in 1996
(from February to August), the new O3:K6 serovar comprised ~75% of all isolated strains
(42).
The new O3:K6, the major pandemic Vp serovar since 1996, has prompted a
tremendous amount of research into classifying both the pandemic strain and closely
related strains (21, 41-44). Several closely related serotypes- O1:K25, O1:K26, O1:KUT
and O4:K68, were discovered to also have pandemic potential and may have originated
from the new O3:K6 clone (41, 43-47). All of the identified potentially-pandemic
serotypes contained tdh but not the trh gene. A method was developed to test the
pandemic-specific group of Vp in 2000, when it was discovered that the toxRS operon
sequence in pandemic-causing strains had a slightly differing nucleotide sequence than
non-pandemic strains (41). The proteins encoded by toxRS are trans-membrane proteins
that are well documented regulators in the Vibrio genus (48-50). Investigators took
advantage of the sequence divergence and developed a PCR method entitled GroupSpecific PCR (GS-PCR) which only amplified pandemic-group Vp toxRS sequences.
Pathogenicity in Vp has been strongly correlated with tdh and trh but has not been
shown as the sole cause of pathogenicity. Virulence factors whose presence is associated
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with these two hemolysins may also contribute to the pathogenicity and virulence of Vp.
In 2003, the sequencing of Vp O3:K6 strain RIMD 2210633 revealed a new virulence
factor: the type III secretion system (T3SS) (23). The T3SS is a needle-like protein
complex found on the surface of some gram-negative bacteria. The rod-shaped needle can
form pores in the membrane of eukaryotic cells and inject specific proteins known as
effectors into the cytosol or environment in response to certain cellular signals or
environmental conditions (51, 52). The genes encoding the T3SS are typically found
clustered together and are commonly found within mobile genetic elements such as
pathogenicity islands (52, 53).
The RIMD2210633 genome revealed not one but two distinct T3SSs: T3SS1 and
T3SS2, located in genetic clusters on chromosomes 1 and 2, respectively. Both T3SSs are
genetically non-redundant and T3SS1 is associated with cytotoxicity while T3SS2 is
correlated with enterotoxicity (54). The T3SS1 in Vp was found to be genetically related
to the plasmid-encoded T3SS of Yersinia pestis, while T3SS2 has been related to the T3SS
system found in Shigella spp. T3SS1 was found to be ubiquitous in Vp while T3SS2 was
found only in KP+ isolates (34, 55). The association of KP+ isolates with T3SS2 was
elucidated when the genes encoding T3SS2 were found residing on an 80kbp pathogenicity
island (23, 56). This pathogenicity island also contained two copies of tdh, effectively
flanking the T3SS (23, 55, 57).
In 2009, a third T3SS variant was discovered in a tdh-/trh+ strain (58) located on
chromosome 2 in the location of T3SS2 in KP+ strains. A study of environmental isolates
from the northern Gulf of Mexico revealed that the new T3SS variant was found in 5/5 tdh/trh+ isolates and 0/153 non- tdh-/trh+ isolates (59). After discovery of this new T3SS
variant on chromosome 2, the original T3SS2 identified in 2003 was renamed T3SS2α.
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The new T3SS variant was named T3SS2β. Thus T3SS2α has been associated with
tdh+/trh- strains while T3SS2β has been associated with tdh-/trh+ strains. Only a minor
amount of research has been done concerning the toxicity of T3SS2β due to its recent
discovery.
Little is known about the T3SS functions in regards to the ability of Vp to enter and
survive inside oyster tissue. Several T3SS genes and their products have been
characterized in Vp since 2003 (60-63), including most structural genes. Many effector
genes and their products have been of particular interest to researchers seeking to
understand T3SS-induced toxicity (37, 60-65). Conversely, there is very little information
regarding which products of T3SS genes are expressed during invasion of Vp in oyster
tissue and hemolymph.
The distribution of virulence factors in Vp isolated from environmental sources
remains unclear. It has been shown that the fitness of Vibrios in the environment is the
result of a combination of genetic factors (66, 67). Therefore, the presence and production
of virulence factors such as the T3SS may confer some change in a strain’s ability to
colonize different environmental compartments such as the water column, biofilms, in
sediment, and the exterior and interior of animals such as filter-feeding oysters.
Vp is widely detectable in oysters harvested from marine and estuarine
environments. Studies in the northern Gulf of Mexico have shown that Vp is detectable in
oyster meat during both warm and cool seasons (7). Although potentially pathogenic Vp is
found at detectable levels in oyster meat, tissue necrosis is not a concern. Conversely,
potentially pathogenic Vp causes both cytotoxicity and enterotoxicity in humans.
Although a large amount of research has focused on characterization of virulence
factors in clinical Vp, little research has focused on naturally-occurring potentially
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pathogenic Vp and their function in the environment. For instance, it is unknown whether
the cytotoxicity of potentially pathogenic Vp varies significantly between strains carrying
tdh or trh. It is also unknown how well the presence of T3SS2 variants α and β correlates
with the presence of hemolysins. More research is needed to understand these rare,
naturally-occurring bacteria in ecologically-relevant situations such as the colonization of
oysters. The ability to understand how naturally-occurring, potentially pathogenic Vp
function in the environment is paramount for developing more effective public health plans
and seafood treatment methods.
The purpose of this study was to examine collections pathogenic and potentially
virulent Vp from environmental sources through the accomplishment of several goals.
•

First, the distribution of the virulence factorT3SS was examined in a large pool
of environmental potentially pathogenic Vp. The distribution of virulence
factors such as tdh, trh, TSSS1, T3SS2α, T3SS2β, and toxRS was correlated to
help better explain their respective role in environmental Vp functions.

•

The correlation of virulence factors and Vp strain fitness was accomplished
through Vp human intestinal epithelial cell cytotoxicity assays and oyster
(Crassostrea virginica) hemocyte bactericidal assays. These assays were
performed and significant differences in cytotoxicity or bactericidal survival
between virulence factor subgroups (tdh+/trh-, tdh-/trh+, tdh-/trh+) was
examined.

•

Significant changes in Vp gene expression was measured for representative
clinical strains of the diametric virulence factor sub-groups tdh+/trh- and tdh/trh+. Transcriptomic changes were measured during exposure to human
intestinal epithelial cells and oyster hemocyte. The relative changes in the Vp
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transcriptome were compared both over time and between strain to give
significantly regulated genes involved in cytotoxicity and oyster hemocyte
bactericidal avoidance.
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CHAPTER II
DISTRIBUTION OF TYPE III SECRETION GENES IN V.
PARAHAEMOLYTICUS FROM THE NORTHERN GULF OF MEXICO
One hundred and thirty potentially pathogenic environmental Vp were selected
from roughly four thousand cultured environmental Vp strains. Three separate
environmental sources (water, sediment, and oyster meat) from the northern Gulf of
Mexico were used for sampling purposes. The 130 isolates comprised roughly 3-5% of
total colonies screened from environmental samples (7) and were considered potentially
pathogenic due to the presence of one or both of the hemolysin genes tdh and trh. Both tdh
and trh were putatively identified in a preliminary colony hybridization screening process.
All isolates were screened for the virulence factors tdh, trh, T3SS1, T3SS2α, and T3SS2β.
All isolates were also examined for a group specific toxRS genetic sequence found in
pandemic-causing strains as previously described (GS-PCR)(18, 41).
Materials and Methods
Sample Collection. Samples were collected in two separate sampling periods with the first
sampling period occurring from October 2006 to August 2007 at sampling sites MS2,
MS5, MS6, and MS8. A second sampling period occurred from February to May of 2009
at sites MS2 and MS8. No sampling occurred in 2008 and sampling was limited to two
sites in 2009 for logistical purposes. Water, oyster, and sediment samples were collected
from the sites in the Mississippi Sound (MS) at the following coordinates: MS2 (30o17.4’
N, 89o17.3’ W); MS5 (30o37.6’N, 88o83.2W); MS6 (30o36.6’ N, 88o67.5’W); and MS8
(30o38.0’ N, 88o 41.1’ W)(Fig 1).
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Figure 1. Locations of the four sampling sites along the Mississippi Gulf Coast. Sampling
sites were designated MS-2, MS-5, MS-6, and MS-8.
Water (6- to 8- liter volumes) was collected in autoclaved plastic containers. Water
conditions varied throughout the sampling period but demonstrated little inter-site
variation. Specifically, the average temperature/salinity was 19.23oC and 17.73ppt for site
MS2, 22.6oC and 22.5ppt for site MS5, 24.6oC and 21.88ppt for MS6, and 20.6oC and
18.1ppt for site MS8. Live oysters (8-15 each sampling trip), water, and sediment were
collected as previously described (7). Vp densities were determined using a previously
described direct plating/colony hybridization method (68), for detection of tdh, trh, and
thermolabile hemolysin (tlh).
Characterization of environmental isolates. The total collection of 130 “potentially
pathogenic” Vp used in this study were collected over the course of two years comprising
over 70 sampling trips and 210 independent enrichments. The tlh+, tdh+, trh+, and
tdh+/trh+ Vp isolates were confirmed as described previously (7) using a Direct Plating /
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Colony Hybridization method (DPCH). In addition, tlh, tdh, and trh were confirmed using
gene specific polymerase chain reaction (PCR) and agarose gel electrophoresis.
Genomic DNA was extracted from each isolate as described previously (7, 69) and
confirmed isolates were stored at ambient room temperature (c.a. 23oC) in soft T1N3 agar
deeps (1% tryptone, 3% NaCl, pH 7.2, 0.7% agar). During the sampling period, 130 tdh+
and/or trh+ Vp isolates were collected for screening of additional virulence factors. Sixteen
tdh-/trh- isolates were chosen randomly to act as negative controls. Twelve clinical isolates
were also included in the analysis and obtained from the U.S. FDA, Alaska Division of
Public Health, American Type Culture Collection, or isolated locally (Table 1).
Table 1
Source of clinical isolates used in this study
Strain ID

Origin

BAA-238

ATCC

BAA-240

ATCC

AQ 4037

A. DePaola, FDA, Gulf Coast Seafood Lab –tlh+/tdh-/trh+ control

FIHES 98

A. DePaola, FDA, Gulf Coast Seafood Lab –tlh+/tdh-/trh- control

Tx2103

A. DePaola, FDA, Gulf Coast Seafood Lab –tlh+/tdh+/trh- control

AK-PHL

T. Franklin, Alaska DPH; infection originated in New Orleans, LA

F11

A. DePaola, FDA, Gulf Coast Seafood Lab

CT6636

B. Tall, FDA – clinical isolate from Connecticut

KCHD 613

B. Tall, FDA – clinical isolate from Washington

Tall 901128

B. Tall, FDA – clinical isolate from Washington
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Table 1 (continued).
Ny3547

B. Tall, FDA – clinical isolate from New York

Vp2007-095

Local clinical isolate

Most clinical isolates were not local and were included to represent a variety of Vp
genotypes which have caused human illness. One clinical isolate, Vp2007-095, was the
single local strain in our collection; it was acquired from a gastroenteritis patient (stool
sample) who had eaten raw oysters.
Screening of environmental and clinical isolates. Three multiplex PCR screens
were performed targeting T3SS1, T3SS2α, and T3SS2β. The T3SS1 multiplex screen
targeted open reading frames (orfs) designated as VP1670 (vscP), VP1686 (putative),
VP1689 (vscK), and VP1694 (vscF). The T3SS2α multiplex was designed to target orfs
VPA1327 (vopT), VPA1335 (vscS2), VPA1339 (vscC2), and VPA1362 (vopB2). The
T3SS2β multiplex targeted genes vscS2, vscC2, vopC, and vopB2 specific for T3SS2β (58).
A preliminary multiplex PCR was originally run against all 158 isolates and targeted
VP1669 (vscO), VPA1346 (vopJ), VPA1354 (vscU2), and an internal control, VPA0226
(tlh). VPA0226, encoding a thermolabile hemolysin, was chosen as an internal control due
to its ubiquitous presence in Vp. Positive amplification of the internal control was
confirmed in the preliminary multiplex before any of the 3 multiplexes were run
All multiplex PCR screenings were carried out using gene-specific primers
(Appendix A). The primers used in this study targeting T3SS2β have been described
previously (58). All other primers, with the exception of primers targeting the hemolysins
and toxRS, are original and were designed by us using primer design software Primer3

13
(http://biotools.umassmed.edu/bioapps/primer3_www.cgi) and tested against selfdimerization and hairpins using the IDT OligoAnalyzer 3.1 software
(http://www.idtdna.com/analyzer/Applications/OligoAnalyzer/). The primers were
screened against the published sequences of chromosomes 1 and 2 of the sequenced strain
RIMD 2210633 and the entire known genetic sequence for T3SS2β+ strain TH3996 to
ensure specificity and protect against cross reactivity. Primer sequences were then run
through BLAST (http://blast.ncbi.nlm.nih.gov/Blast.cgi), using a modified BLASTN
algorithm designed for oligonucleotide primers.
PCR cycling conditions for the tdh, tlh, and trh multiplex included an initial
denaturation at 95oC for 2 minutes, 33 cycles of denaturation at 95oC for 45 seconds,
annealing at 56oC for 45 seconds, and extension at 72oC for 40 seconds, and a final
extension at 72oC for 3 minutes. The amplification conditions for T3SS1 and T3SS2α
multiplexes were set at one cycle of 95oC for 5 minutes, followed by 33 cycles of
amplification consisting of denaturation at 95oC for 45 seconds, annealing at 60oC for 40
seconds, and extension at 72oC for 45 seconds, and terminated by one cycle of final
extension at 72oC for 3 minutes. For the T3SS2β multiplex PCR parameters were assigned
as previously described (58). Group Specific PCR (GS-PCR), targeting a region of the
toxRS specific to pandemic-causing groups, was performed as described previously (41).
After amplification, the products were resolved by gel electrophoresis using a 1.3%
agarose gel run at 200 volts in sodium borate buffer (SBB) to resolve 100-600 bp
amplicons. Primers were designed so that amplicon sizes were distinguishable for each
multiplex set. Agarose gels were then stained using Sybr Gold (Invitrogen, Carlsbad, CA).
After staining, gels were viewed in order to record presence or absence of amplicons. In
the case of faint amplicon bands, PCR multiplex screens were rerun to confirm results. To
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confirm amplification of the correct product, a monoplex PCR for each gene target was run
with the appropriate positive control- strain Tx2103 for T3SS1 and T3SS2α genes and
strain AQ4037 for T3SS2β genes. Amplicons from the monoplex were purified from
agarose (Qiagen, Valencia, CA) and sent out for sequencing (McLab, San Francisco, CA).
Recognition and identification of vopB2 using fluorescence in situ hybridization. A
technique known as Recognition of Individual Gene Flurescence in-situ Hybdridization
(RING-FISH), originally documented in 2004 (70), was used to confirm the presence of
virulence factors in specific Vp strains. Vp strains were grown overnight at 37oC in 1mL of
alkaline peptone water (APW) and fixed as described previously (71) on 4-well, 5-mm
teflon printed slides (Electron Microscopy Sciences, Hatfield, PA). The vopB2 primers
used for the development of an RNA probe were identical to the T3SS2α vopB2 primers
used for the PCR screen with the exception that the forward primer contained an additional
21-bp segment encoding the binding site of the T3-RNA polymerase (Appendix A).
Transcription and probing was performed as described previously (70) with the following
changes. The vopB2 RNA probe was fluorescently labeled via incorporation of CY3dUTP (GE Healthcare) during transcription. Hybridization was carried out with an initial
step of 80oC for 20 minutes followed by 38oC for 24 hours in humidity controlled
chambers. After, hybridization slides were washed with deionized water and counterstained with Fluoro Gel II with DAPI (Electron Microscopy Sciences, Hatfield, PA).
Slides were then placed in storage at 4oC. All slides were viewed with a Zeiss Axiostar
Plus microscope (Carl Zeiss, Germany) using the appropriate filter set. Vibrio
parahaemolyticus cells were examined in the appropriate slide well and counted. Under
visualization, if no cells produced a Cy3 fluorescence the result was considered negative.
Cells which were positive for RING-FISH generally resulted in cells that fluoresced
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equally across the slide. Some cells on positive slides did not produce fluorescence;
however these cells generally were in areas of debris which may have affected the ability
for the probe to bind. Methodology and cell compatibility was first tested using the
ubiquitous Vp gene tlh (K.J. Griffitt, unpublished data). Cell images were acquired using
Zeiss AxioCam MR camera and AxioVision software v4.7.1.0 (Carl Zeiss).
Results
Vp isolates were screened for genes representative of T3SS1, T3SS2α, and T3SS2β
(Tables 2 and 3).
Table 2
Distribution of virulence factors in environmental isolates (n=146)
tdh+/trh-

tdh-/trh+

tdh+/trh+

tdh-/trh-

T3SS1

27/27

3/3

100/100

16/16

T3SS2α

27/27

0/3

0/100

0/16

T3SS2β

0/27

3/3

0/100

0/16

GS-PCR

0/27

0/3

0/100

0/16

Table 3
Distribution of virulence factors in clinical isolates (n=12)
tdh+/trh-

tdh-/trh+

tdh+/trh+

tdh-/trh-

T3SS1

3/3

2/2

4/4

3/3

T3SS2α
T3SS2β

3/3
0/3

0/2
2/2

0/4
0/4

0/3
0/3
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Table 3 (continued).
GS-PCR

0/3

0/2

0/4

0/3

A total of 158 strains were tested in this experiment, 146 environmental strains and
12 clinical strains. Among the 146 environmental isolates collected, 130 were considered
potentially pathogenic (tdh and or trh) with 16 identified as non-pathogenic because they
contained neither tdh nor trh. The 16 non-pathogenic isolates were selected at random as
representative of the overall non-pathogenic Vp population. A total of 12 clinical isolates
(three tdh+/trh-, two tdh-/trh+, four tdh+/trh+, and three tdh-/trh-) were also tested. In total,
100 (77%) of 130 potentially pathogenic Vp isolates were tdh+/trh+, 27 (21%) were
tdh+/trh-, and 3 (2%) were tdh-/trh+. Of the 12 clinical isolates tested, 2 were tdh-/trh+, 4
were tdh+/trh+, 3 were tdh+/trh-, and 3 were tdh-/trh-. All 158 Vp isolates tested positive for
all 5 T3SS1 genes selected.
Five genes associated with T3SS2α were used to screen the 158 isolates. Of the
146 environmental isolates, 27/27 tdh+/trh- isolates tested positive for 4 out of 5 T3SS2α
genes, with all 27 testing negative for vopB2. All 3 tdh+/trh- clinical isolates tested positive
for all T3SS2α genes, including vopB2. No other isolate tested positive for any T3SS2α
gene. The presence/absence of vopB2 was confirmed using recognition of individual gene
fluorescence in situ hybridization (RING-FISH) with specific gene probes as described
previously (70). All 3 clinical tdh+/trh- strains exhibited the normal positive signal pattern
after hybridization with a 250-bp VPA1362 RNA probe, while 27/27 environmental
tdh+/trh- strains did not produce any positive signal after hybridization (Figure 2).
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Figure 2. Representative images of Vp isolates tested using RING-FISH for T3SS2α gene
vopB2. (A.) 1000X magnification DAPI image of tdh+/trh- vopB2- environmental isolate
2007-103. (B.) Cy3 image of identical slide location for environmental isolate 2007-103.
(C.) DAPI image of vopB2+ clinical isolate Tx2103. (D.) Cy3 image of identical slide
location for clinical isolate Tx2103
Aside from vopB2, no gene was detected differentially between clinical and
environmental isolates. Therefore RING-FISH was run solely for the vopB2 gene.
Group-specific PCR (GS-PCR), targeting a region commonly associated with
tdh+/trh- isolates was also used to screen all isolates. No environmental isolates were
positive for GS-PCR. All 3 clinical tdh+/trh- isolates positively amplified using GS-PCR.
No other clinical isolates produced an amplicon.
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T3SS2β genes vscC2, vscS2, vopB2, and vopC were screened against all 158
isolates. Of the 30 tdh+/trh- strains, all tested negative for T3SS2β genes. All 5 tdh-/trh+
strains tested positive for each T3SS2β genes. No other isolate tested positive for T3SS2β
genes (Table 2).
All environmental strains in this study were isolated from the water column,
sediment, or oyster meat (Figs. 1, 3).

Figure 3. The percent distribution of potentially pathogenic Vp. (A) Distribution of
isolates by hemolysin content over two separate sampling years. (B) Distribution of total
isolates and of isolates in three environmental sources (oyster, water, and sediment). (C)
Distribution of isolates by sampling site.
Of 130 potentially pathogenic environmental strains isolated, 73 (56%) were
isolated from sediment, 27 (21%) from oyster, and 30 (23%) from water. We found 59%
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of tdh+/trh- isolates in sediment, 19% from oyster samples, and 22% from water. Out of
100 tdh+/trh+ isolates, 54% were taken from sediment samples, while 22% and 24% were
isolated from oyster and water respectively. All 3 environmental tdh-/trh+ isolates were
found in the sediment.
The single local clinical strain, VPA2007-095, tested negative for both T3SS2 and
GS-PCR and tested positive for tdh, trh, and T3SS1. This result was also the most typical
result for all 130 environmental strains that were screened.
Discussion
This study represents a rare look at the distribution of a poorly understood
community of naturally-occurring bacteria from which human pathogens can arise.
Although the great majority of infections come from Vp isolates containing tdh and/or trh
and epidemiological evidence has correlated the two gene products (hemolysins) with
pathogenicity (29), almost all naturally-occurring (environmental) isolates lack these two
hemolysins (72, 73). Therefore, human infections most commonly arise from rare,
naturally occurring tdh+ and/or trh+ Vp strains found in finfish, shellfish, coastal waters
and sediment.

On average, during the 2007 sampling period tdh- and trh- positive

isolates represented 3% and 1% of the total (tlh+) environmental Vp detected in this study,
respectively (7).

We were able to acquire a large pool of potential pathogens (tdh+ and/or

trh+) by enriching environmental samples and isolating individual colonies that contained
either tdh or trh. Each enriched sample plate yielded anywhere from 1-10 colonies
containing tdh and/or trh with an average of less than 2 colonies per plate. Several
colonies from the collection were analyzed for genetic diversity using REP-PCR and
MLSA data (31) including several suspected duplicate colonies. Two sets of isolates were
found to be identical by REP-PCR: Vp2007-020/Vp2007-023 along with Vp2007-043/
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Vp2007-047. Interestingly, the data from this paper also showed that colonies containing
tdh and/or trh from the same plate did not necessarily have the same genetic fingerprint or
allelic profile, thus colonies coming from the same plate could not be dismissed as
identical strains.
The genetic compliment in Vibrio greatly affects their function in nature (67).
Several Vp pathogenicity factors have been discovered, including TDH, TRH, urease, and
pili (3, 27, 74, 75). The presence of other pathogenicity factors such as the T3SS may alter
a bacteria’s fitness or ability to colonize certain environments such as host organisms
including oysters. Since the Gulf of Mexico is the major producer of oysters used for raw
consumption in the United States (76), this possibility has public health implications.
However, our data shows a similar distribution between oyster, water, and sediment
regardless of the presence of hemolysins or T3SSs (Figure 3). The only exception to this
has been with tdh-/trh+ isolates which were found only in sediment.
Only three tdh-/trh+ isolates were identified throughout the sampling period and all
three isolates were found in the sediment at sampling site MS6 (Figs 1, 3). The
temperature and salinity of site MS6 at the time each of the 3 tdh-/trh+ isolates were
collected were not significantly different from other sampling sites. Although there does
indeed appear to be a bias as to at which site tdh-/trh+ isolates were found, temperature and
salinity do not appear to be major factors; further investigation of site MS6 may better
explain this isolate collection anomally.
In a separate study it was demonstrated that Vp outnumbered V. vulnificus in the
sediment but not in oysters or in the water column (C.N. Johnson, mss in prep). Turbidity
also played a large role in the densities of Vp and the sediment. Both suggest that sediment
may play a large role in Vp growth and survival and introduction into the water column.
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This study examined the distribution and variation of T3SS in Vp. Genes were
selected based on relative necessity/function of the related protein in the secretion system,
physical distribution in the T3SS gene cluster, and fidelity across the genome. In the case
of T3SS2β, genes were chosen based on homology to T3SS2α genes that were also
targeted in this screening. Three of the four T3SS2β genes screened have a homologous
T3SS2α gene which was also screened: vscC2, vscS2, and vopB2, with 70%, 74%, and
70% homology, respectively. All 158 isolates tested positive for all 5 T3SS1 genes,
confirming earlier reports of T3SS1 being ubiquitous in Vp (23, 54). T3SS2α, which has
been shown to correspond with tdh+/trh- strains (34, 54), was found in all 30 tdh+/trhsamples, regardless of whether that isolate was GS-PCR positive. No other isolates tested
positive for any of the five T3SS2α genes present in the screen. The discovery of a T3SS2
variant, T3SS2β, was made relatively recently (58) and has been confirmed in this study as
being present in 5/5 tdh-/trh+ isolates. To our knowledge this is the first reported case of
T3SS2β genes identified in Vp from the Gulf of Mexico.
While most Vp serotypes are noninfectious, the few infectious serotypes can
become major agents of outbreaks worldwide (24, 34). In 1996, a pandemic strain was
discovered in Calcutta and was described as a “new” O3:K6 type strain that was different
from previously described clones and carried tdh but not trh (28). Ample evidence has
linked tdh+/trh- strains of Vp with pandemic-causing serotypes (18, 28, 41, 47, 77). We
have reported that roughly 20% of all potentially pathogenic isolates collected in this
experiment were tdh+/trh-; we screened 158 isolates using GS-PCR (41) for identification
of any isolates belonging to the pandemic-causing group. Out of 27 environmental
tdh+/trh- isolates, none tested positive for GS-PCR. However, all three clinical tdh+/trhisolates tested positive. The three clinical isolates that tested positive were all donated by
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the FDA (Table 1). No other isolate, environmental or clinical, tested positive for the
toxRS amplicon, including the single local clinical isolate. The non-amplification of GSPCR on the local clinical isolate is not surprising as there have been no reported cases of
the pandemic clone, O3:K6, being found in the Gulf of Mexico. Unsurprisingly all
environmental isolates tested negative for GS-PCR as well.
Aside from variations between the overall T3SS2 gene cluster, not all individual
genes identified as part of the Vp T3SS2 have been found in all isolates, allowing for some
minor intra-species variation. VPA1362, an orf encoding the effector protein VopB2 in
T3SS2α, was found in this study to be absent from all environmental tdh+/trh- isolates and
present in all clinical tdh+/trh- strains. The gene vopB2 was the only gene to be present
differentially between environmental and clinical strains. The absence of vopB2 in
environmental strains appears to be specific to the T3SS2α variant. The T3SS2β vopB2
gene variant (73% homology to T3SS2α VPA1362) was found in all tdh-/trh+ isolates, not
only clinical strains.
All four T3SS2β genes targeted in this screen were positive in all five tdh-/trh+
isolates. This confirms the previous report of T3SS2β being found in tdh-/trh+ strains. The
T3SS2β variant was recently discovered by Okada et al (58) and other T3SS2-related
genes have been reported (78). The history of genetic transfer of T3SS in Vp is not well
understood but the fidelity between hemolysin content and type of T3SS was observed in
this experiment. Instinctively this makes sense as T3SS2β was shown to be near trh in the
genome, while genetically T3SS2α is flanked by tdh.
The majority of potential pathogens we observed in this study were positive for
both tdh and trh. All of these isolates tested negative for both T3SS2α and T3SS2β. This
may be due to the fact that all primers targeting T3SS genes in Vp have been designed
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using sequences solely from tdh+/trh- and tdh-/trh+ isolates. A third T3SS2 variant may
reside in tdh+/trh+ isolates, yet be undetected due to significant sequence divergence. A
clear example of this came in 2009 when T3SS2β was discovered in strains thought to be
lacking a T3SS2, although T3SS2α sequences had been known for 6 years. In order to
compensate for lack of sequenced Vp genomes, future studies may include adapting RINGFISH to target typical T3SS2 genes in Vp and screening isolates using a less stringent
annealing method in order to detect homologues with moderate similarity.
Currently, the pathogenicity island on chromosome 2 of Vp in which the T3SS2 is
located has been demonstrated to contain either tdh and T3SS2α or trh and T3SS2β, but
not both sets. There is currently a lack of genetic sequence data for strains containing both
tdh and trh. However, understanding the genetic structure of the pathogenicity island in
tdh+/trh+ strains may be important as we have observed these strains to make up a large
portion of the environmental “potentially pathogenic” isolates.
In addition to lack of knowledge about tdh+/trh+ isolates, tdh-/trh- isolates also have
not been well characterized, although they make up the vast majority of environmental Vp
isolates. In one report, four T3SS2-related genes were found to exist in non-toxigenic
strains and were found to be actively transcribed (78). Although our results contradict
those reported by Caburlotto et al. (78), it is difficult to hypothesize why these differences
occurred. For instance, Caburlotto et al. examined Vp in the Venetian Lagoon while this
study examined populations in the Gulf of Mexico, vastly separate areas with differing
environmental conditions. Little is known about the genetic distribution of spatially
separated Vp populations. Although we have not observed T3SS2 genes in any of our tdh/trh- isolates, additional strains from the northern Gulf of Mexico are being gathered for
further characterization of pathogenicity factors.
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In conclusion, our study has taken advantage of a unique opportunity provided by
a large collection of potentially pathogenic environmental isolates to examine the presence
of T3SS variation in Vp. We have reinforced the observation that T3SS1 is present in all
Vp strains. Furthermore, the presence of T3SS2α, which has been most frequently
associated with pathogenic Vp, was shown to coexist with tdh but was absent from all
isolates containing trh in this study, confirming previous reports from other regions in the
world. T3SS2β was detected in all tdh-/trh+ isolates, suggesting the two versions of T3SS
are exclusive to their respective hemolysin profile and also confirmed the presence of
T3SS2β in tdh-/trh+ isolates. As more information is discovered about the presence and
distribution of pathogenicity factors like the T3SS in Vp, analysis of natural populations
should be used to better understand the relationship between genetic content and diversity
in the environment.
About This Chapter
The work in this chapter was published March 2010 in the Journal of Applied
Microbiology (ISSN 1364-5072) (59).
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CHAPTER III
VARIATION IN SURIVIVAL RATES OF POTENTIALLY VIRULENT V.
PARAHAEMOLYTICUS EXPOSED TO OYSTER HEMOCYTE
The presence of virulence factors such as tdh, trh, and the T3SSs have been shown
to have a significant effect on Vp pathogenesis in humans (79, 80). It remains unclear what
role these factors have in host immune system avoidance for Vp residing in oyster tissue or
in other marine animal tissues. In this experiment, we collected and typed 28 nonhomologous Vp strains and challenged them with oyster (C. virginica) hemocyte
bactericidal assays. Isolates were screened in parallel for the presence of tdh, trh, T3SS1,
T3SS2α, and T3SS2β and sorted into pathogen sub-groups based on the presence of
hemolysins tdh and trh. Hemocyte-induced bactericidal activity, through a calculated
Hemocyte Killing Index (KI), was compared between pathogen sub-groups to determine if
virulence factors have any influence.
Caco-2 cells, a human adenocarcinoma cell line, were also challenged with
specific strains of Vp used in this experiment to determine if any relationship existed
between toxicity in human intestinal epithelial cells and the presence of virulence factors.
Variations in Vp cytotoxicity were analyzed between pathogen sub-groups and compared
with Vp abilty to avoid killing by oyster hemocytes.
Materials and Methods
Bacterial Strain Isolation. Beginning in August 2007, water, oyster, and sediment
samples were collected in four sites in the Mississippi Sound and transported on ice
immediately to the laboratory for bacterial isolation. Vp isolates were identified using a
direct plating/colony hybridization method described previously (7) with markers for tlh,
tdh, and trh. Vp isolates that were positive for tdh and/or trh were picked, sub-cultured and
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confirmed. Each isolate was then screened for T3SS1, T3SS2α, and T3SS2β using PCR
(Appendix A). These screens were performed using three separate multiplex reactions
targeting a total of 12 genes with gene-specific primers. All PCR primers, with the
exception of those targeting T3SS2β, were original and designed to produce amplicons of
distinct separate sizes(59). After each isolate was characterized for the presence of
virulence factors tdh, trh, T3SS1, T3SS2α, and T3SS2β, they were checked on nonspecific T1N3 agar plates for contamination. For long-term storage, all cultures were
placed in T1N3 agar deeps with oil. For short-term use over the course of this study,
cultures were taken from long-term storage, grown on T1N3 agar plates at room
temperature, and placed in a 12oC environment to slow growth. When needed, the agar
plates were taken from 12oC and allowed to warm up to room temperature.
Preparation of Vp strains, hemocytes, and Caco-2 cells for cytotoxicity challenges.
A total of 28 strains were tested in oyster hemocyte bactericidal assays. All strains tested
can be found in Appendix B. Individual colonies were picked and grown overnight at 37oC
in 15mL of APW for cytotoxicity challenges. Pure Vp cultures grown this way and
sampled the next day contained an average density of 3-4x107 cells ml-1 (data not shown).
After overnight growth, cells were pelletted at 3000g for 5 minutes and washed twice with
PBS. Cells were re-spun after wash and re-suspended in sterile PBS at the appropriate
volume to achieve final seed dilution of 1x105 cells per challenge. Bacterial seed densities
remained constant in both oyster hemocyte and Caco-2 cytotoxicity challenges.
Eastern oysters (Crassostrea virginica) were gathered from the same sample sites
where Vp was collected (Figure 1, pg 9). Oysters were transported on ice to the lab where
they were immediately sacrificed for hemolymph. Specifically, a ½” notch was made with
a sterile shucking knife at the ventral posterior edge of the oyster shell. Immediately, a
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sterilized glass syringe fitted with a 23 gauge needle was inserted into the adductor muscle
and hemolymph was drawn out and placed in polystyrene tubes on ice to prevent
clumping. Care was taken not to draw mantle fluid in. The total time from oyster shell
notching to hemocyte extraction was approximately 90 seconds for each oyster. The
required volume of hemocyte needed for each 96-well challenge plate was pooled from 815 oysters. After hemocyte collection, a hemocytometer was used to determine densities
and hemocyte concentration was adjusted to ~2x105 cells ml-1. A dye exclusion assay was
performed by diluting a subsample of hemolymph 1:5 with a 0.4% Trypan Blue solution.
Hemolymph was then observed under a light microscope (Zeiss) to confirm presence and
viability of hemocytes
Caco-2 cells, acquired from the American Type Culture Collection (ATCC) were
grown in culture flasks (Falcon) containing Eagles Minimum Essential Media (EMEM)
with 20% Fetal Bovine Serum (FBS) at 37oC in 5% CO2. No antibiotics were used in
Caco-2 culture. Cells were passed 1-2x per week. Vp toxicity challenges took place
between passages 8-15.
Cytotoxicity challenges. All Vp cytotoxicity challenges were based on previously
published hemocyte and Caco-2 killing assays (81-85). Each Vp strain involved in a
cytotoxicity assay was tested in triplicate. Assays were done using 96 well plate flat
bottomed plates (Falcon). Each plate seeded with ~1x104 oyster hemocyte or Caco-2 cells
per appropriate well. Sterile artificial seawater (ASW) was used as the media in hemocyte
challenges, while EMEM was used in Caco-2 challenges. In hemocyte cytotoxicity trials,
each plate was spun down at 180g for 10 minutes prior to addition of Vp to promote
hemocyte attachment. Oyster plasma was then removed and replaced with PBS. 1x105 Vp
cells of a specific strain were added to achieve a final multiplicity of infection (MOI) of
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10. This MOI was chosen based on previous Vp cytotoxicity work (82-84). After addition
of both hemocyte/Caco-2 and Vp cells, each plate was spun down (Eppendorf 5430R) at
4oC and 160g for 10 minutes to promote Vp attachment.
Hemocyte cytotoxicity challenges were placed at room temperature (20oC) and
incubated for 5 hours. Caco-2 cytotoxicity challenges were incubated at 37oC and 5% CO2
for 5 hours.
Cytotoxicity was measured via 3-(4,5-Dimethylthiazol-y-yl) (MTT) assay, which
measures cell viability by assessing mitochondrial activity through colorimetric analysis of
a reduced formazan dye end product. Specifically, a clear chemical product is added to the
well. Active mitochondria convert this colorless product into an insoluble dye, which
precipitates out to give a purple color. A relationship can be established between dye
absorbance and cell density, thus providing an estimate for cell viability. Twenty five uL
of APW was added to each well along with the MTT compound after incubation. An
additional 2 hour grow-out/recovery period was provided after which the challenge was
stopped using a solubilization solution. After dye solubilization, each plate was read at
570nm and 725nm absorbance using a SpectraMax M2 plate reader (Molecular Systems).
The KI and % bacterial survival in oyster hemocyte cytotoxicity challenges were
calculated using the following formulas (85):
Oyster Hemocyte KI = 1 – [ (AbsHB – AbsH)/ AbsB]
% Vp Survival = 100* (1- KI)
The cytotoxicity of Vp to Caco-2 cells was calculated with the following formula:
Caco-2 Death = 1- [(AbsCB-AbsB)/ AbsC]
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Results
A total of 29 strains of Vp were tested for the ability to survive exposure to oyster
hemocytes. Nine tdh+/trh+, nine tdh+/trh-, four tdh-/trh+ , and six tdh-/trh+ Vp strains were
tested. The hemocyte survival % +/- Standard Deviation (SD) was 43.6 +/- 21.8, 51.7 +/21.9, 47.2 +/- 10.1, and 58.7 +/- 14.6 for tdh+/trh+, tdh+/trh-, tdh-/trh+ , and tdh-/trh+ ,
respectively (Table 4, Figure 4).
Table 4
Vp survival in Oyster Hemocyte
tdh/trh

Sum

n

Avg Survival(%)

Std Dev

Std Error

+/+

508.161

9

43.538

21.846

7.282

+/-

435.145

9

51.651

21.864

7.288

-/+

211.173

5

47.207

10.096

5.048

-/-

248.121

6

58.647

14.643

5.978
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Figure 4. The percentage of Vp cells still viable after 4 hour oyster hemocyte bactericidal
assays, separated by potential pathogen subgroup. Standard error bars are shown.
Twenty-five strains of Vp were additionally tested for their respective cytotoxic
potential when exposed to Caco-2 cells (Table 4, Figure 5). Caco-2 Cytotoxicity was
defined as the percentage of Caco-2 cells still alive after a four-hour exposure to an
individual Vp strain. Caco-2 cytotoxicity +/- SD was measured at 56.7 +/-13.1, 56.17 +/29.5, 25.6 +/- 20.26, and 43 +/- 30.75 for tdh+/trh+, tdh+/trh-, tdh-/trh+ , and tdh-/trh+
isolates, respectively.
Table 5
Percentage of Caco-2 cell death after exposure to Vp
tdh / trh

Sum

n

Avg Kill %

Std Dev

Std Error

+/+

510.7

9

56.74

13.130

4.377
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Tabled 4 (continued).
+/-

337.0

6

56.17

29.451

12.023

-/+

128.0

5

25.60

20.256

9.059

-/-

215.0

5

43.00

30.749

13.751

Figure 5. The percentage of Caco-2 cells killed after a 4 hour Vp-Caco-2 cytotoxicity
assay. Standard error bars are shown.
A student’s t-test (α = 0.05) was used to evaluate any significant differences in
oyster hemocyte survival between potential pathogen subgroups (Table 6). Potential
pathogen subgroups were also tested for significant differences in cytotoxicity of Caco-2
cells (Table 7).
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Table 6
Student t-test p values for Vp virulence factor sub-group comparisons in oyster hemocyte
bactericidal assays
(tdh/trh)

+/+

+/-

-/+

-/-

+/+

-

0.539

0.929

0.471

+/-

-

-

0.538

0.972

-/+

-

-

-

0.446

Table 7
Student t-test p values for Vp virulence factor sub-group comparisons in Caco-2
cytotoxicity assays
(tdh/trh)

+/+

+/-

-/+

-/-

+/+

-

0.569

0.0119*

0.295

+/-

-

-

0.092

0.552

-

-

0.386

Table 4B (Continued).
-/+

-

*Significant Difference at α=0.05

No meaningful relationships between presence of virulence factors and ability to
survive oyster hemocyte killing were observed. There was a significant difference in Vp
survival rates between strains of clinical and environmental sources (p=0.028, α = 0.05),
which is consistent with previous reports (86). No significant difference was found
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between environmental and clinical strains of Vp during Caco-2 exposures (p=0.80 α =
0.05).
One potential pathogen subgroup, tdh-/trh+, displayed significantly different
cytotoxicity in Caco-2 assays than the tdh+/trh+ subgroup (p value 0.0119). While
insignificant, a p-value of 0.092 was found in a comparison of tdh-/trh+ and tdh+/trhsubgroups for cytotoxicity in Caco-2 assays.
Not all strains of Vp tested for oyster hemocyte survival were tested for Caco-2
cytotoxicity due to logistical and technical difficulties. Each of the strains tested for Caco-2
cytotoxicity had been previously tested for oyster hemocyte avoidance. No strains were
tested for Caco-2 cytotoxicity that had not been previously challenged for a hemocyte KI.
There was a loose negative correlation between Caco-2 cytotoxicity and oyster
hemocyte killing avoidance with an r value of -0.43. Vp strains with varying presence of
virulence factors tdh, trh, and T3SS2 variants α and β did not contribute differently to
bacteria exposed to oyster hemocyte or Caco-2 cells with one exception (tdh-/trh+
subgroup in Caco-2 cytotoxicity tests).
Discussion
The use of a reduced dye compound to measure Vp bactericidal activity in oyster
hemocyte has been well documented (82, 85) and provides a reliable mechanism to study
bacterial responses to immunological activity in vitro. The results of C. virginica hemocyte
bactericidal activity in this study correlated with previous published reports of tests on
some of the same clinical Vp strains as tested in this experiment (82, 86). The majority of
Vp strains used in these challenges were environmental isolates and therefore unique to this
experiment; however, some well-established clinical strains have previously been
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examined. In the current experiment, Tx2103 was found to have a hemocyte KI of 55%,
whereas previous reports displayed a KI of ~52% for the same strain (86).
The correlation of virulence factors in bacterial species and their fate after exposure
to oyster hemocyte has been studied but is still not well understood (85-88). Reports
indicated that Vp hemocyte bactericidal activity was correlated with season (82) and the
nature of the strain (environmental vs clinical) (86). In this experiment, all oysters
collected for hemocyte exposure were done between July and August of 2010. Mean water
temperatures did not vary significantly to affect hemocyte activity, although the high
summer temperatures could have provided an increased bactericidal activity as previously
reported (82).
Both environmental and clinical strains were tested in this experiment, including
one local clinical isolate, Vp2007-095JW. Each virulence factor subgroup tested contained
at least one clinical and environmental sample. A list of all strains tested can be found in
Appendix B.
Caco-2 human intestinal epithelial cells were chosen to investigate the cytotoxic
ability of Vp. Specifically, Caco-2 cells were chosen because these cells differentiate into
intestinal epithelial cells (89) when grown to confluence and express the appropriate
intestinal epithelial membrane proteins. Previous studies of Vp cytotoxicity have been
performed using Caco-2 cells as a reliable and practical in vitro cytotoxicity assay (62, 80,
84, 90-92). All Caco-2 cultures used in cytotoxicity assays were harvested after a
minimum of 8 passes, thereby assuring the development of epithelial tight junctions and
appropriate display of surface antigens (93) in the culture monolayer.
In both oyster and Caco-2 assays, potential pathogen sub-groups did not display
any significant difference with one exception. There was a significant difference in Caco-2
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cytotoxicity of tdh-/trh+ and tdh+/trh+ isolates (p= 0.012). The average Caco-2 killing
capacity of strains in these two virulence factor sub-groups was 19.8% and 58.5%,
respectively. These results indicate that tdh-/trh+ isolates could be less effective; however,
even though the results were statistically significant the data set is too small to provide a
conclusive association. Over a period of four years, we were only able to isolate three
environmental tdh-/trh+ isolates. The reason behind the rarity of these isolates in the
northern Gulf of Mexico is not well understood and acts as a natural limit on statistical
analysis in this experiment.
The oyster hemocyte bactericidal assay data indicated that there was significant
interstrain variance with regards to survival in bactericidal conditions. No differences
could be seen by separating out the strains via potential pathogen sub group. Similar trends
were seen in the Vp-Caco-2 cytotoxicity assays.
Overall, there was a weak negative correlation (r= -0.43) between Vp cytotoxicity
in Caco-2 cells and survival in oyster hemocyte exposures. However, the significance of
this correlation must take into account the experimental models. Caco-2 cytotoxicity
assays, by necessity, take place in a media rich cell-culture environment widely different
from the environment found in oyster hemocyte assays. Furthermore, Caco-2 assays only
function as a model for cytotoxicity, the assays are significantly different from the
environment of the human gut.
Interactions between tissue (hemocyte or Caco-2 monolayer) and Vp cells also
occur in each experimental assay and may affect results. Many virulence factors in Vp such
as T3SS1 and T3SS2 may be differentially expressed under various environmental
conditions including contact with different cell types (94, 95).
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Signaling processes controlling large genetic systems may take more time than
available in these assays and is a limiting consideration for this type of experiment. For
instance, Vp transitions between growth in a liquid medium (swimmer) and growth on a
surface (swarmer) by shifting expression profiles of key genes such as the polar flagellum
(96-99). These transcriptomic shifts are also responsible for the expression and repression
of some virulence and secretion genes (100).
The bactericidal and cytotoxicity assays in this report were done over a four hour
time course, as determined by preliminary MTT data (not shown) and previously published
experiments (82, 84, 101). This experiment allows for good short-term standardized data to
be gathered for Vp immune-avoidance by controlling bacterial starting densities, tissue
densities, and total exposure time, but sacrifices the depth and detail of a microcosm-type
experiment. Future research using microcosms and long-term (multiple week) exposures to
oysters could illicit a more complete understanding of the relationship between virulence
factor and bactericidal activity.
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CHAPTER IV
TRANSCRIPTIONAL REGULATION IN POTENTIALLY VIRULENT V.
PARAHAEMOLYTICUS DURING EXPOSURE TO INTESTINAL EPITHELIAL CELLS
AND OYSTER HEMOLYMPH
The presence and absence of specific genes in environmental and clinical Vp strains
have been well studied, while genetic expression studies of Vp are much more uncommon
in the current literature. The study of gene expression can be prohibitive for a number of
reasons including cost and quality of experimental design. Of the gene expression studies
in Vp that have been reported, the majority have been performed on specific targeted
subsets of genes (94, 102-108). Few genome-wide Vp studies have been done (109, 110).
This study examined the genetic expression differences between groups of
pathogenic, potentially virulent clinical Vp strains using whole genome DNA microarrays.
Specifically, two clinical Vp strains representative of distinct pathogenic subgroups were
challenged with Caco-2 human intestinal epithelial cells and oyster hemolymph over a four
hour exposure. The purpose of this study was to identify genes significantly differentially
expressed in potentially virulent strains of Vp over time and between pathogenic groups.
Understanding the role of potentially virulent bacteria in the environment is a key
step in discerning the relationship between these organisms and public health risk. It has
been well documented that the vast majority of clinical Vp cases involve strains represent
only a small portion of the overall Vp community in the environment (7, 8, 73). A recent
survey in the northern Gulf of Mexico indicated roughly 4-5% of Vp isolates sampled
contained relevant virulence factors (31). Furthermore, this study indicated that the
majority of these isolates were found in sediment or oyster; tdh-/trh+ isolates were found
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only in the sediment. Current similar studies continue to show such patterns in potentially
virulent Vp (Johnson 2012, mss in prep).
We chose to study the regulation of genes involved with Vp exposure to oyster
hemolymph by analyzing bacterial transcriptomic responses over time. Vp is found
naturally in oyster tissue, yet the relationship between potentially virulent Vp and oyster
colonization is unclear, if indeed they colonize oyster tissue. It is possible that Vp exists
transiently in oysters. Multiple experiments have shown that Vp is depurated at varying
rates in molluscs including oysters, but do not completely rid themselves of Vp (111-113).
By analyzing the expression responses in potentially virulent Vp exposed to oyster
hemolymph, a relationship between genetic capability and environmental functionality
could be elucidated.

Furthermore, we chose to corroborate thesis data with expression

data gathered from Vp exposure to Caco-2 adenocarcinoma cells. Caco-2 cells, once grown
to confluence, differentiate in to human intestinal epithelial cells. Both oyster hemolymph
and Caco-2 exposure designs provide basic in-vitro mechanisms for understanding
complex in-vivo functions.
Materials and Methods
Bacterial Strains. Two Vp strains, TX2103 and AQ4037 were chosen for this study
as representatives of the pathogen subgroups tdh+/trh-/T3SS2α+ and tdh-/trh+/T3SS2β +.
The two Vp strains chosen are the FDA reference strains used for potentially virulent
subgroups. AQ4037 is the strain in which TRH was originally discovered (27). It should
also be noted that Tx2103 belongs to the pandemic O3:K6 serovar, while AQ4037 is of the
non-pandemic (or pre-pandemic) O3:K6 serovar. The presence of tdh, trh, and T3SS genes
was confirmed using gene-specific PCR (Table 2, pg 14). All strains were acquired from
the FDA (Appendix B).
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Strains were kept on T1N3 agar deeps at room temperature for long term storage
and T1N3 plates at 15oC for short-term storage. Cultures were re-plated every four weeks
and examined for contamination. For microarray analysis, cultures were removed from
short-term storage and individual colonies were plated onto Thio-Citrate-Bile-Salt (TCBS)
agar plates and incubated at 37oC overnight. After confirmation on TCBS plates, colonies
for each strain were placed into 15mL 10X Alkaline Peptone Water (APW) and grown for
18 hours at 37oC. Cultures were then enumerated using both plate count and
hemocytometer. The procedure of inoculating in APW through enumeration was repeated
multiple times to ensure consistent and reproducible bacterial concentrations for each
strain.
Prior to gene expression challenges, each strain was grown overnight in 10X APW
at 37oC. Afterwards, the cultures were pelletted by centrifugation at 2200g for 10 minutes
followed by removal of the growth media. Cells were then washed with Phosphate
Buffered Saline (PBS) and respun. After this, Vp pellets were resuspended in PBS and
diluted 1:5 for a final concentration of 1.1x106ml-1. This concentration was chosen to give
a Multiplicity of Infection (MOI) of 10 in the challenges.
Caco-2 culture. For genetic expression analysis Vp was challenged with both Caco2 colorectal adenocarcinoma cells and oyster hemocyte. Caco-2 cells display
characteristics of enterocytic differentiation once they have reached confluence and were
acquired from the American Type Culture Collection (ATCC). The cells were grown in
Eagles Minimum Essential Media (EMEM) (ATCC) with 20% Fetal Bovine Serum
(FBS)(ATCC) at 37oC in 5% CO2. Cells were passed two times per week at roughly 80%
confluence. All Vp toxicity challenges took place between passages 8-15. For Vp
challenges, Caco-2 cells were passed and 16 additional flasks (Falcon) were inoculated
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with trypsinized Caco-2 cells. The doubling time for Caco-2 cells is approximately 62
hours; prior to inoculation, the cell concentration was checked with a hemocytometer.
Once the concentration was known, each flask was seeded with an initial concentration of
~2.5x104mL-1 cells per flask with the objective of reaching a final concentration of
1x105mL-1 cells in a confluent layer, thus achieving the stated MOI of 10.
Collection of oyster hemolymph. Acquisition of a large volume of oyster
hemolymph was accomplished by harvesting Crassostrea virginica oysters directly from
the environment. Specifically, all oysters were collected locally in areas identical to where
local Vp were acquired (see Chapter 2). Once oysters were collected, oyster hemolymph
was pooled from multiple oysters and placed immediately on ice to prevent cell
aggregation. Specifically, oyster hemolymph was extracted as previously described (81)(K.
Burnette, personal correspondence) with some modifications. Specifically, oysters were
notched on the posterior edge with a pair of sterilized pliers. Next, a sterile glass syringe
with a 23gauge sterile needle was inserted through the cavity and into the adductor muscle.
Hemolymph was drawn directly from the adductor muscle, with great care taken not to
extract mantle fluid as well. Consistent with previous reports, roughly 1-5 ml of
hemolymph were collected per oyster (81, 82). After hemolymph was collected and
pooled together on ice, hemolymph concentrations were measured using a hemocytometer
and diluted with sterile ASW to 1 x 105 ml-1. Cell enumeration was performed as
described previously (114) using hemocytometry to determine viable cells using dye
exclusion. Trypan blue, chosen for dye exclusion, was combined with hemolymph
suspension and injected into a hemocytometer. All stained and unstained cells were
counted in the four corner chambers of the hemocytometer and cell number determined.
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Bacterial Challenges. To determine levels of Vp gene expression during exposure
to various tissue types, two representative Vp strains were challenged with two differing
tissue types: oyster hemolymph and Caco-2 cells. The experiment was comprised of 32
separate challenges; each bacterial strain was challenged with each tissue type at two
separate time points, 1 hour and 4 hours. These time points were chosen based on
preliminary growth data with media only (Figure 6 and 7).

Figure 6. Vp growth over time (minutes) when exposed to Caco-2 cells in EMEM
with 10%FBS.

Figure 7. Vp growth over time (minutes) in oyster hemolymph assays.
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Each challenge (specific time point, strain, and tissue type) was repeated in
quadruplicate to ensure reproducibility and to identify any irregularities in individual
arrays. In oyster hemolymph challenges, the pooled and iced oyster hemolymph was
enumerated and seeded into 6 well culture plates (BD Falcon) as previously described (82)
with slight modification. Specifically, 3 x 105 hemocyte cells (3mL of 1x105) were seeded
per well and spun down for 10 minutes at 180g. Next the serous fluid was removed, the
wells were washed with ASW, and the culture plates were respun. Finally, the ASW was
removed and the correct volume of bacteria (3mL of 1x106) was added to achieve a final
MOI of 10. The culture plates were respun a final time for 5 minutes at 180g to promote
bacterial adhesion. At each time point (1 and 4 hours), half of the sample was carefully
removed via pipette and immediately purified for RNA.
Caco-2 challenges were performed with identical time points and MOI as the oyster
hemocyte challenges to allow for inter-tissue time-point gene expression comparisons.
Each of the 16 separate Caco-2 challenges was done in individual flasks where the human
intestinal epithelial cells had reached confluence. Specifically, after flasks had reached
confluence, Vp was added at the correction concentration and the flasks were spun down at
180g for 5 minutes and placed back in 37oC 5% CO2 incubators. At each time point
Vp/Caco-2 suspension was removed by pipette and immediately purified for RNA.
RNA Extraction and Labeling. RNA taken from bacterial challenges was
immediately stabilized with Qiagen RNAprotect and purified with Qiagen RNeasy mini kit
as per the manufacturer’s suggested protocol (QIAGEN). After purification, RNA was
checked on a NanoDrop 1000 (ThermoSci ) for concentration and contaminants. Once
each RNA sample passed NanoDrop analysis, the sample was then loaded and run on a
Bioanalyzer 2100 (Agilent) to confirm that there was no degradation.
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After quality confirmation, each RNA sample was labeled for microarray analysis.
RNA was labeled as per Pathogenic Functional Genomics Resource Center (PFGRC)
instruction. Specifically, RNA was reverse transcribed using PowerScript RT (Invitrogen)
in the presence of random hexamers and 25mM dNTP/aa-UTP labeling mix. The ratio of
aa-UTP to dTTP was set at 2:1. Amino-allyl labeled cDNA was then purified using Qiagen
MinElute (QIAGEN) kit, substituted a specific phosphate wash and elution buffer. After
purification, the aa-cDNA was chemically labeled with a Cy3 dye ester and then repurified
using the MinElute kit. Final analysis of the Cy3-labeled cDNA probe was done on a
NanoDrop1000. Total dye incorporation and incorporation ratio was calculated. Probes
were pelleted using a Vacu-fuge (Eppendorf) and stored short-term in the dark at -80oC
until hybridization.
DNA microarrays. The microarrays used were designed and produced by the J
Craig Venter Institute (JCVI)
http://pfgrc.jcvi.org/index.php/microarray/array_description/vibrio_parahaemolyticus/versi
on1.html). The JCVI produced these microarrays in the Pathogen Functional Genomics
Resource Center (PFGRC) which was awarded to them by the National Institute of Health
(NIH) National Institute of Allergy and Infectious Disease
(http://www.niaid.nih.gov/Pages/default.aspx). The Vp microarray plates were awarded to
this project after an application was submitted to the PFGRC.
The PFGRC microarrays used in this study correspond to the Vibrio
parahaemolyticus v1 arrays. The design of the microarray is a standard glass slide with an
aminosaline coating, printed with 21,168 spots distributed in 48 grids. The spots account
for double-coverage of each of the 9,442 70mer oligonucleotides, along with controls. Vp
oligonucleotide probe sequences were designed from Vp strains RIMD2210633, AQ3810,
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and plasmid pO3K6, and from V. cholera El Tor N16961. Annotation files are available
for viewing at
http://pfgrc.jcvi.org/index.php/microarray/array_description/vibrio_parahaemolyticus/versi
on1.html.
Microarrays were hybridized with Cy3 cDNA probes as per PFGRC instructions.
Arrays were prehybridized with a 20xSSC/10%SDS/1%BSA solution at 42oC for one
hour. Prehybridized slides were then washed, placed in alcohol, and dried extremely
carefully to prevent streaks or spots on the array. The hybridization buffer used was a 40%
formamide, 5xSSC, 0.1%SDS solution with 0.6ug/ul Salmon Sperm DNA added as a
blocking agent. The hybridization buffer was then combined with the lyophilized probe
and heated at 95oC for 10 minutes. Next, microarrays were hybridized using a a-Hyb
hybridization station (Miltenyi) at 42oC for 20 hours. Array hybridization was limited to 4
at one time. After hybridization, microarrays were washed and scanned using a VersArray
scanner (BioRad).
Expression Analysis. Analyses of scanned microarray images were done using the
TM4 Microarray Software Suite (http://www.TM4.org). Specifically, Spotfinder v3.2.1
was used for initial image analysis. Hybridized microarray images were received in dual
layer TIFF format after scanning and loaded into Spotfinder. Next, grids were created
semi-automatically using the listed PFGRC parameters and manually aligned to the array
images. Spot intensities were determined using the Otsu segmentation method to subtract
background noise. Annotation files were added, with the final Spotfinder analysis
providing calculated intensities, background values, spot position/gene identifiers, and
quality control flags.
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Statistical analysis was accomplished using JMP Genomics software (SAS). After
image analysis, data from Spotfinder was saved and loaded into JMP Genomics.
Distribution analysis was accomplished for all 32 microarray files. After distribution
analysis the data was standardized and a Correlation and Principal Components analysis
was done. Normalization was then confirmed and significant differentially expressed genes
were discovered using two-way Analysis of Variance (ANOVA). ANOVA was used to
compare microarray data through inter-strain, inter-tissue, and time point comparison.
Minimizing the variance and noise of expression in microarray data sets is pivotal
to making meaningful predictions. PFGRC Vp microarrays were designed with double
coverage of all available probes. In this experiment, significant differentially expressed
genes were recorded on a per-spot, not per-gene, basis. This was chosen to prevent underrepresentation of significantly expressed genes through mechanisms such as physical
sources of variation that occur spatially on the microarray. PFGRC arrays are spotted glass
slides and therefore subject to variation from both the slide and printing apparatus. The
application of a per-spot analysis along with quadruplicate biological replicates allows for
the normalization of several sources of variance while at the same time emphasizing the
identification of significant genes.
Results
The expression of the 9,442 genes gathered from each of the 32 Vp microarrays
was analyzed using TM4 Microarray Suite and SAS JMP Genomics software. Each
experimental sample was performed in quadruplicate to increase robustness of the results.
The spot intensity levels for each array was normalized, grouped, and compared using a
two-way ANOVA statistical test to predict up and down regulation of genes. Statistical
tests were run comparing expression of individual Vp strains over time for each tissue

46
types, as well as comparing the expression of genes between strains at identical time points
and tissue type. No analysis was done to compare genetic expression between Caco-2 and
oyster hemocyte challenge groups.
In each strain, genes were identified as significantly up or down-regulated based on
changes in levels of expression between the chosen time points of 1 to 4 hours. These time
points were chosen after preliminary growth data (Figures 5A/B) demonstrated that once
Vp cultures were seeded in their respective tissue type, Vp maintained a lag phase for
roughly two hours before entering the exponential phase of growth. The initial time point
of one hour was chosen to allow time for the bacteria to acclimate and gene expression
reflect the environmental. The time point at 4 hours was chosen to prevent rising culture
densities from shifting the MOI greatly and to also prevent the over-accumulation of
degraded cells from having an effect on environmental chemistry such as pH, [CO2], [O2],
etc.
Regulation of genes in individual strains. A total of 475 genes were found to be
significantly differentially expressed between time points for each strain in similar tissue
challenges (Table 8).
Table 8
Summary of all genes significantly up or down-regulated in each Vp challenge group
Strain

Caco-2

Oyster Hemolymph

Up

Down

Up

Down

Tx2103

39

24

80

72

AQ4037

35

31

120

74
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A list of all significant up or down-regulated genes can be found in (Appendix C).
Over the course of the experiment in hemolymph tissue challenges Tx2103 significantly
up-regulated 39 genes and down-regulated 24. AQ4037 regulated (up/down) 35/31 genes.
In Caco-2 tissue, Tx2103 significantly regulated (up/down) 80/72 genes over time, while
AQ4037 contained 120/74 significantly regulated genes.
Following identification of significant genes, functional categories for each of the
significantly expressed genes was determined and genes were grouped according to
specific function. The total number of genes in each category can be found in Figures 8
and 9.

Genes regulated in Vp-oyster hemolymph
challenges
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Figure 8. Total genes regulated in Vp-oyster hemolymph challenges. Genes are separated
into categories: Meta-Metabolism, Hypo-Hypothetical, Regulation, Trans/Sec- Transport
and secretion related, Motility and Chemotaxis, Bio-Biofilm/attachment related, Virvirulence related genes.
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Genes regulated in Vp-Caco2
challenges
60
50
40
30
20
10
0
TX

AQ

Metab

TX

AQ

Hypo

TX

AQ

TX

AQ

Regulation Trans/Sec
Upregulated

TX

AQ

Motility

TX

AQ
Bio

TX

AQ
Vir

Downregulated

Figure 9. Total genes regulated in Vp-Caco-2 challenges. Genes are separated into
categories: Meta-Metabolism, Hypo-Hypothetical, Regulation, Trans/Sec- Transport and
secretion related, Motility and Chemotaxis, Bio-Biofilm/attachment related, Vir-virulence
related genes.
Functional categories consisted of metabolism (carbohydrate, lipid, amino acid,
and nucleic acid), transport/secretion, motility/chemotaxis, regulatory proteins,
hypothetical and conserved proteins, biofilm/attachment, and virulence-related genes.
Generally, the number of genes up and down regulated over time in each category for
individual strains was similar, with some exceptions. The ratio at which Tx2103 upregulated to down-regulated metabolic genes was 4.0 (16/4) in oyster tissue compared to
AQ4037, which regulated metabolic genes at a ratio of 1.15 (15/13). This pattern was not
observed in Caco-2 challenges where the ratio of up to down-regulated genes was 1.25 for
Tx2103 and 1.85 for AQ4037.
The majority of significant genes expressed over time for each strain took place in
Caco-2 challenges (346) compared to oyster hemolymph (129). When separated by
category, the ratios of genes regulated (# up-regulated genes / # down-regulated genes) in
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Caco-2 challenges compared to oyster hemolymph challenges were 2.92, 2.625, 1.8, and
2.5 for metabolism, hypothetical, regulation, transport/secretion, and chemotaxis,
respectively. The ratio of total genes regulated in each tissue type was also separated by
strain and category (Figures 10-12).

Ratio of Gene Regulation in Oyster
Hemolymph Challenges Upregulated/Downregulated
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Figure 10. Ratio of significantly up-regulated to down-regulated genes in oyster
hemolymph challenges for each functional gene category and challenge type. Ratios are
separated for each strain and gene functional group. Numbers greater than one indicate
more up-regulated genes, numbers less than one indicate more down-regulated genes.
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Ratio of Gene Regulation in Vp-Caco-2
Challenges Upregulated/Downregulated
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Figure 11. Ratio of significantly up-regulated to down-regulated genes in Caco-2
cytotoxicity challenges for each functional gene category and challenge type. Ratios are
separated for each strain and gene functional group. Numbers greater than one indicate
more up-regulated genes, numbers less than one indicate more down-regulated genes.

Figure 12. Ratio of total number of genes expressed by strain (Tx2103/AQ4037). Numbers
greater than one demonstrate more regulated genes in Tx2103, 1 means equal number of
regulated genes between strains, and numbers less than one reveal more regulated genes in
AQ4037.
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Notably, in AQ4037 nine chemotaxis genes were regulated in Caco-2 challenges,
while only one was regulated in oyster challenges. This is in contrast to the four genes
regulated by Tx2103 in both oyster and Caco-2 challenges.
The number of genes regulated in the hypothetical protein gene category varied
significantly between challenge groups and strains. A ratio was determined by totaling the
number of genes both up and down-regulated in each Vp strain for both challenge groups
(Caco-2 and oyster hemocyte). The total number of significantly regulated genes in Caco-2
challenge groups was divided by the total number of significantly regulated genes in oyster
hemocyte challenge groups. The ratio of regulated genes in Caco-2 challenges to oyster
hemolymph challenges was markedly in the hypothetical protein gene category.
Specifically, the ratio in Tx2103 was 1.96 compared to 3.53 in AQ4037. In other terms,
Tx2103 regulated twice as many hypothetical proteins in Caco-2 challenges, while
AQ4037 significantly regulated almost four times the number of hypothetical genes in
Caco-2 challenges than in oyster hemocyte challenges. The proportion of regulated
hypothetical genes compared in all significantly regulated genes remained consistent
between challenge groups, 31.0% and 30.3% for oyster and Caco-2 challenges
respectively.
No biofilm/attachment or virulence genes were detected as being significantly
differentially expressed in oyster hemolymph challenges, however 11 total genes from
these categories were found to be significantly regulated in Caco-2 challenges (Table 9).
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Table 9
Total genes up or down-regulated by category. O – Oyster, C – Caco-2
Metab

TxO
AQO
TxC
AQC

Hypo

Regulat

Trans

Chemo

Dw

Up

Bio

Up

Dw

Up

Dw Up

Dw

Up

Dw

Up

16

4

12

11

3

3

5

5

3

1

0

15

13

10

7

7

5

3

5

0

1

35

28

25

20

7

8

8

12

3

50

27

38

22

11

6

14

11

5

Vir

Dw

Up

Dw

0

0

0

0

0

0

0

1

1

2

1

1

4

1

2

1

2

Interstrain variation in expression of genes. A total of 523 genes were found to
have significant interstrain variation at corresponding time points and tissue types (Table
10).
Table 10
Total summary of genes displayed significant expression variation between strains at equal
time points/challenge groups
Metab

Hypo

Regul

Trans

Chemo

Bio

Vir

AQ TX

AQ

TX AQ TX AQ TX

AQ

TX AQ TX AQ TX

Oys- 1h

5

23

2

9

0

1

1

4

2

0

0

0

0

0

Oys - 4h

4

41

12

7

2

2

1

7

0

1

0

0

0

0

Caco - 1h

19

34

21

19

5

10

5

8

3

2

2

0

3

5

Caco - 4h

73

44

36

38

13

8

18

11

6

4

1

3

7

1
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A total of 241 genes were expressed at a higher level in AQ 4037 across all time
points and challenge groups while 282 genes were expressed at a significantly higher level
in Tx2103. In oyster tissue challenges, Tx2103 contained 95 genes significantly higher
expressed than AQ4037,while AQ4037 only expressed 29 genes at higher rates than
Tx2103. These results are markedly different from the Caco-2 challenge where Tx2103
displayed 187 genes at higher levels than AQ4037 and AQ4037 contained 212 genes that
were expressed at significantly higher levels than Tx2103(Figure 13 and 14).

Number of genes with significant
Interstrain Variation in Vp-Oyster
Hemolymph challenges
45
40
35
30
25
20
15
10
5
0
1h

4h

Metab

1h

4h

Hypo

1h

4h

1h

4h

Regulation Trans/Sec
TX

1h

4h

Motility

1h

4h
Bio

1h

4h
Vir

AQ

Figure 13. Total number of genes significantly differentially expressed between strains at
equal time points in Vp-oyster hemocyte challenges.
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Genes with Significant Interstrain
Variation in Vp-Caco2 challenges
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Figure 14. Total number of genes significantly differentially expressed between strains at
equal time points in Vp-Caco-2 challenges.
Of the 241 genes expressed in higher amounts in AQ 4037, the vast majority (88%)
came from the Caco-2 challenge group, while Tx2103 had only 66% (187) of genes from
the Caco-2 challenge group. This discrepancy is most visible in the metabolism gene
category. The ratio of metabolic genes expressed higher in Tx2103 to AQ4037 was 7.1 and
0.85 in oyster hemolymph and Caco-2 challenge groups, respectively. The large
discrepancy of genes expressed to higher degrees in Tx2103 to AQ4037 in oyster
hemolymph can be further broken down by time point- at one hour the ratio was 4.6 while
at four hours the ratiowas 10.25. The time point ratios in the Caco-2 challenge groups give
almost the exact opposite effect, with the ratios of 1.79 and 0.60 for the one hour and four
hour time points, respectively (Figure 15-17).
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Tx2103/AQ4037 Ratio of Total
Interstrain Expression Variation
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Figure 15. Ratio of Tx2103 differentially up-regulated genes to AQ4037 differentially upregulated genes across all time points for each gene functional category. The challenge
groups are separated.

Ratio of Interstrain Expression
Variation in Oyster Hemolymph
Challenges - Tx2103:AQ40367
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Figure 16. Ratio of Tx2103 differentially up-regulated genes to AQ4037 differentially upregulated genes for each gene functional category in oyster hemocyte bactericidal assays.
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Figure 17. Ratio of Tx2103 differentially up-regulated genes to AQ4037 differentially upregulated genes for each gene functional category in Caco-2 cytotoxicity assays.
The disparity of strain expression ratios can be further seen in the
transport/secretion gene category. In the oyster hemolymph challenge group, the ratio of
transport and secretion genes expressed higher in Tx2103 compared to AQ4037 is 5.5,
with ratios of 4.0 and 7.0 for the one and four hour time points, respectively. In the Caco-2
challenge group, the ratio is 0.83 with one hour and four hour time points corresponding to
the ratios 1.6 and 0.61.
The largest disparities in significant gene expression between strains can be found
in metabolism genes at the four hour oyster challenge time point (10.25) and virulence
genes at the four hour Caco-2 challenge time point (7.0). Virulence genes were not
significantly expressed between strains in any oyster challenge. In Caco-2 challenges,
Tx2103 significantly expressed more virulence genes at the early time point (1.67 ratio)
than at the late time point (0.14 ratio).
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Discussion
This project was designed to gain a deeper understanding of how Vp differentially
expresses genes between potential pathogen subgroups in a naturally- occurring extreme
environment such as exposure to oyster hemocyte. The experimental design to acquire the
RNA samples for analysis was based on previous oyster hemocyte bactericidal assays
(Chapter III). There is currently little data available on Vp transcriptomic responses to
oyster hemocyte.
An identical experimental design to the oyster hemocyte bactericidal assay was set
up based on Vp-Caco-2 cytotoxicity assays. The transcriptomic data gathered from Caco-2
cytotoxicity experiments were used as points of comparison for hemocyte assays.
Transcriptomic data from Vp in cytotoxicity assays is extremely useful when utilized as a
comparison tool, but becomes much weaker as a stand-alone model when assessing Vp
responses to environmental conditions. The Caco-2 models provide an excellent method
for in vitro studies of bacterial cytotoxic potential but are not designed as a proxy for the
human gut environment.
The genetic cross-talk of tissues and bacteria must be taken into account when
analyzing the Vp transcriptomic response in these assays. Mussel hemocytes regulate
defense and immune-related genes at varying rates for different bacteria (115, 116). For
instance, it has been demonstrated that hemocytes contribute to bactericidal activity
through phagocytosis (117). Phagocytosis can be enhanced through the production of
enzymes such as integrin and are well regulated in oyster hemocytes (118). It has also been
demonstrated that different Vibrio species can cause different gene regulatory responses in
mussel hemocyte (116, 119); however, the degree to which strains of a single species
differentially affect hemocyte gene expression is unknown. The analysis of the
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transcriptomic response of Vp in oyster hemocyte bactericidal assays was done recognizing
the environmental variability caused by tissue ‘cross-talk’. The genetic regulation of oyster
hemocyte was not studied in this experiment. Care was taken to normalize all hemocyte
tissue samples. All hemolymph was pooled and maintained at an identical cold temperature
to reduce clumping and promote uniformity during attachment. Oysters collected for
hemocyte extraction were done on the same reef within a specific range of temperature and
salinity.
Caco-2 cells express genes which have a profound effect on Vibrio pathogenicity
and virulence. Caco-2 cells differentiate into intestinal epithelial cells when grown to
confluence in a monolayer and display multiple surface antigens. Several virulence factors,
such as the T3SS, can cause multiple changes in gene regulation in target cells such as
Caco-2 (37, 61, 62, 120-124). It has been previously reported that different potential
pathogen subgroups contain differing T3SS (among other virulence factors) in Vp (59),
therefore there may be differing pathways of contribution to overall cytotoxicity.
Mechanisms used by the T3SS can cause different and complex signaling cascades in
Caco-2 cells, altering Caco-2 gene expression (120, 125, 126). Therefore, variance in
genetic ‘feedback’ must be taken into account when interpreting interstrain Vp expression
in Caco-2 cytotoxicity assays.
Gene expression was measured by examining the differences in gene expression as
opposed to analyzing the absolute transcriptomic response at each time point. Emphasis
could be placed on those genes most likely effecting current environmental conditions by
focusing on only genes which were up or down-regulated during an exposure. As such,
there were a total of 475 genes identified as significantly up or down regulated in a
combination of both strains and challenge groups (Appendix A), with 58% total genes
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being up-regulated. Neither strain was directly favored in identification of regulated genes
over time, 45% of all regulated genes came from Tx2103 while AQ4037 comprised 55%.
We found that the PFGRC Vp microarrays performed without showing bias. The JCVI
PFGRC microarrays used in this experiment contained 70mer probes based on sequence
data from available Vp genomes, which is limited and comprised mainly of the tdh+/trhO3:K6 pandemic clone and variants thereof. Inherently, this could favor the Tx2103 strain.
While both Tx2103 and AQ4037 are of the O3:K6 serovar, Tx2103 bears a closer genetic
relationship to the pandemic clone RIMD2210633, as both are tdh+/trh-/T3SS2a+, while
AQ4037 is tdh-/trh+/T3SS2B+. We found no evidence of this through analysis of available
expression data.
Metabolic differences in strains exposed to oyster hemocyte. The functional gene
group Metabolic Processes contained the most number of genes in the oyster hemocyte
bactericidal challenge groups with 37% of all regulated genes. In the hemocyte assays,
Tx2103 and AQ4037 up-regulated a similar number of genes, 16 and 15 respectively.
AQ4037 repressed metabolic genes at a significantly greater number of genes than
Tx2103- 13 genes compared to 4.
Tx2103 down-regulated a quinone and putative oxidoreductase, a DNA helicase
ruvB, and a murein transglycolase. Quinone reductase has been demonstrated in Vp to be
part of a respiration-driven sodium pump (127) that responds under alkaline conditions.
Murein transglycolases alter the peptidoglycan layer of the cell during growth and
development (128). AQ4037 down-regulated several genes involved in amino acid
metabolism and synthesis, glycolysis, and DNA synthesis. The majority of metabolic
genes down-regulated were involved in protein metabolism (46%).
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Genes up-regulated by AQ4037 in the oyster hemolymph challenges included lipid
metabolism and biosynthesis, ribosomal biosynthesis, electron transport, and several
stress-related genes. Two siderophore synthesis genes were up-regulated, pvsA and an
acsD homologue, suggesting Vp AQ4037 was operating under iron limiting conditions.
PvsA is a vibrioferrin biosynthesis compound synthesized under iron limiting conditions,
while the acsD gene contains conserved domain sequences akin to the Erwinia
acrhomobactin biosynthesis protein (129). A general stress resistance gene in E. coli, rpoS
was up-regulated which induces a variety of genes including starvation genes (130).
Carbon starvation is considered one of the primary inducers of RpoS (131, 132).
Tx2103 up-regulated several metabolic genes involved in fatty acid metabolism
and biosynthesis, lipid biosynthesis, and oxidative phosphorylation, but did not up-regulate
any stress-related or starvation-induced genes. The discrepancy between down-regulated
metabolic genes in Tx2103 and AQ4037 could be due to an increased level of fitness of
tdh+/trh- potentially virulent Vp in oyster tissue. AQ4037 up-regulated several stressinduced genes and siderophores. The majority of genes up-regulated by Tx2103
corresponded to biosynthesis and metabolism. In a separate study of over four years, the
presence of potentially virulent Vp in oysters from the northern Gulf of Mexico was
examined. While several tdh+/trh+ and tdh+/trh- were cultured from oyster meat, no tdh/trh+ isolate was cultured from oyster tissue (31, 59).
While Vp growth in preliminary experiments was very similar for each challenge
group, we hypothesize that the diluted EMEM media in Caco-2 experiments could have
provided nutrients and compounds unavailable to the Vp strains in the oyster hemolymph
challenges. The cellular content of Caco-2 cells also differs from oyster hemocytes which
could affect the available resources for Vp if these cells were lysed. Furthermore, the Caco-

61
2 and hemolymph challenges were run in separate distinct environmental conditions: Caco2 challenges were done at 37oC with 5% CO2 in diluted EMEM while oyster hemolymph
challenges were done at 22oC in 18 ppt ASW with no media supplementation. For these
reasons, there was no examination of differences in gene expression between tissue groups.
The Caco-2 challenges presented contrasting metabolic expression data to the
oyster hemolymph challenges. The Vp strain AQ4037 up-regulated twice as many
metabolic genes as down-regulated. Tx2103 up-regulated several metabolic genes involved
in DNA/RNA synthesis, stabilization, and repair as well as two genes coding for proteins
involved in the breakdown of peptidoglycan. Alcohol dehydrogenase and glutathione
peroxidase were also up-regulated, suggesting oxidative stress. Conversely, Tx2103 downregulated several genes involved in carbohydrate metabolism, biosynthesis, and electron
transport.
AQ4037 up-regulated a wide variety of metabolic genes including fatty acid
synthesis and metabolism, sugar metabolism, RNA synthesis, and electron transport.
Down-regulated genes included amino acid metabolism and biosynthesis, DNA repair and
synthesis, sugar biosynthesis and metabolism, and a single heat-shock protein, related to
DnaJ.
Shifts in Patterns of Localized Hypothetical Gene Expression in Vp-Oyster
Hemocyte Assays. A total of 145 hypothetical and conserved genes were significantly up or
down-regulated over time in both Caco-2 and oyster hemocyte assays. Combining data
from both strains, more hypothetical genes were up-regulated in Caco-2 challenges (72%)
than in oyster challenges. Some of the hypothetical genes were found to have metabolismrelated conserved domains which could partly explain why hypothetical genes were
regulated at greater frequency in Caco-2 challenge groups than in oyster hemolymph.
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Vp contains two chromosomes of 3.29Mbp (I) and 1.88Mbp (II). Both
chromosomes contain an identical percentage of protein coding regions with nearly
identical average coding length (23). Chromosome I contains most of the essential growth
and viability genes including copies of each tRNA gene; chromosome II contains some
essential genes and genes related to regulation and transport. Chromosome II is considered
to have a role in environmental adaptation (23).
In the oyster hemolymph challenges, Tx2103 significantly regulated more genes on
chromosome II than AQ4037 in oyster hemolymph (13 to 2), but not in Caco-2 cells (23 to
34). Since chromosome II has been related more to environmental adaptation, these
hypothetical proteins could be involved in pathways which helps Tx2103 adapt to the
oyster environment. Both strains regulated a similar relative number of genes on
chromosome I in both challenge groups. While many regulated hypothetical genes contain
putative conserved domain sequences such as permeases, ATPases, and Rf2 transcriptional
regulator, multiple hypothetical genes with no predicted function were seen regulated
across both strains. Specifically, in oyster hemolymph challenges DUF-family motif
hypothetical genes VP0752 and VP0836 were up-regulated, while DUF-motif containing
hypothetical gene VPA1284 was down-regulated. It should be noted that VPA1284 was
the only hypothetical gene on chromosome II which AQ4037 significantly down-regulated
in oyster hemolymph challenges.
Transport, Attachment, and Virulence expression in oyster hemocyte and Caco-2
cytotoxicity assays. Tx2103 up-regulated several sodium symporter genes in oyster
hemolymph challenges, which is intuitive when taking into account the both the halophilic
nature of the bacterium and high sodium environment. Vibrios can produce ATP with a
sodium motive force (127). Also, in Vp the polar flagella are driven via a sodium pump
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while lateral flagella are driven with a proton pump (133). In the oyster hemocyte assays
Tx2103 up-regulated flagellar proteins including the hook protein and motor flagellumspecific ATP synthase. Tx2103 down-regulated genes involved in potassium uptake and
macrolide-specific efflux proteins. These results suggest that Tx2103 was able to take
advantage of the halophilic environment of the hemolymph challenge. AQ4037 upregulated only 3 transport/secretion genes in oyster hemolymph. All up-regulated genes
were ABC transporters, including one hemin transporter. The up-regulation of the hemin
transporter corresponds with the increase in siderophore gene transcription seen in
AQ4037 oyster hemolymph challenges. AQ4037 also down-regulated few
transport/secretion genes, of note the outer membrane protein ompV was down-regulated,
which functions in NaCl regulation in Vp (134).
The general functions of transport/secretion genes regulated in Caco-2 trials were
different from hemolymph trials in both strains. Tx2103 up-regulated a single
sodium/proline symporter along with multiple outer membrane proteins, secretion proteins,
and a sodium-type flagellar protein precursor. Down-regulated genes included multiple
ABC transporters, a sodium/glutamate symporter, MSHA-related attachment proteins, and
ExbD2, a TonB system transport protein. The TonB system in gram-negative bacteria
helps to transmit the proton motive force from the cytoplasmic membrane to the outer
membrane, where it can be used to fuel multiple functions (135).
In Caco-2 challenges, AQ4037 preferred motility to attachment. AQ4037 upregulated several motility-related genes including flhB, flhF, CheZ, flgE, and two flagellar
and biofilm-related proteins. 42% of all down-regulated genes in AQ4037 were adhesion
related proteins, including pilZ, a type IV pilus assembly protein.
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Very few virulence factors were detected as being significantly regulated in any
strain or challenge group. These results can be explained by the relationship between
quorum-sensing, nutrient density, and virulence. It has been shown that surface sensing in
Vp promotes genetic expression of colonization and virulence genes (106, 136, 137).
Furthermore, virulence factors such as the T3SS can be induced by the limitation of certain
nutrients such as iron and calcium (136) and under certain cell densities (100).
Specifically, Vp and V. harveyi have been shown to secrete virulence factors under lowdensity conditions through an auto-inducing signaling cascade. This has been demonstrated
in an opposite manner to Enterohemarrogenic E. coli, which secrete T3SS proteins at high
cell densities (138). Experiments showing virulence production under low-density
conditions occurred over a 14 hour time frame, while the short nature of these tissue
exposures could have not provided the time necessary to promote observable changes in
genetic expression. It should also be noted that while limited calcium is a proven promoter
of T3SS gene expression, both challenges took place in calcium rich environments.
Overall, many significant differences in genetic expression were found between Vp
strains in oyster hemocyte bactericidal assays. These differences were further illustrated by
analyzing the transcriptomic response of Vp in a cytotoxic-inducing environment and
comparing the results to Vp-hemocyte gene regulation. This study has demonstrated that
tdh+/trh- and tdh-/trh+ strains of Vp significantly differ in many functional categories when
exposed to oyster hemocyte.
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CHAPTER V
CONCLUSIONS AND FUTURE DIRECTIONS
Potential pathogen Vp subgroups displayed unique and separate characteristics
throughout this project. Only 130 potentially pathogenic Vp strains out of thousands
isolated from the northern Gulf of Mexico were found to contain tdh and/or trh.
Approximately half of these strains came from sediment, the remaining strains were
isolated evenly between water and oyster tissue. Only three tdh-/trh+ isolates were found
over four years of sampling, and all occurred in sediment at one site. REP and ERIC-PCR
showed that these strains shared strong homology but were not identical. Thesis data
suggest that in the northern Gulf of Mexico the environment may be more favorable to
potentially pathogenic Vp that carry tdh.
A representative tdh+/trh- Vp strain up-regulated metabolic, hypothetical, transport,
and secretion-related genes at a significantly higher frequency than a representative tdh/trh+ strain in oyster hemocyte bactericidal assays. Furthermore, the tdh-/trh+ strain
induced multiple stress response genes. These same expression patterns were not seen in
Caco-2 cytotoxicity assays. The oyster bactericidal assay contained lower nutrients and
were more indicative of natural conditions compared to the Caco-2 cytotoxicity assays. It
is unsure if the differences in genetic expression were due to the lower nutrient
environment or the presence of hemocytes or both.
The potential pathogen subgroups of Vp did not display any significant difference
in bacterial oyster hemocyte assays. This suggests that neither tdh+/trh- nor tdh-/trh+
subgroups are better equipped to deal with hemocyte exposure. Differences in regulated
genes between subgroups is therefore slightly more likely due to be a response of
environmental conditions, not the presence of hemocytes.
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The results of these experiments indicate that metabolism plays a strong role in
how potentially pathogenic Vp isolates are distributed in the environment and that
metabolic factors may be useful indicator of potentially pathogenic strains. Future research
should acknowledge that this data used representative clinical strains for expression
studies. The rarity of tdh-/trh+ isolates in the northern Gulf of Mexico is a double-edged
sword- it is both an interesting discovery and a limitation to the significance that can be
placed on data acquired from potential pathogen subgroup analysis. An experiment which
is able to test a large collection of environmental and clinical tdh-/trh+ isolates could help
increase the significance of these findings.
The functions of all organisms are extremely complex at the molecular level. A
strong assessment of relevant genetic characteristics, such as transcriptomics, in Vp
provides a good framework for additional research but cannot be generalized.
Environment, time, and cell densities are some of many variables which affect Vp. The
combination of genetic and organism-level experiments help to ensure a lucid
understanding of potentially pathogenic Vp and their role in the environment.
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APPENDIX A
OLIGONUCLEOTIDE PRIMERS USED IN THIS STUDY
Name

Sequence

Reference

tdh_89F

TCCCTTTTCCTGCCCCC

(139)

tdh_321R

CGCTGCCATTGTATAGTCTTTATC

(139)

trh_20F

TTGCTTTCAGTTTGCTATTGGCT

(139)

trh_292R

TGTTTACCGTCATATAGGCGCTT

(139)

tl_884F

ACTCAACACAAGAAGAGATCGACAA

(139)

tl_1091R

GATGAGCGGTTGATGTCCAAA

(139)

VP1669F

TACCGAGTTGCCAACGTG

This Study

VP1669R

GATTGTTCCGCGATTTCTTG

This Study

VP1670F

ACCGATTACTCAAGGCGATG

This Study

VP1670R

TACGTTGTTGGCGTGATTGT

This Study

VP1686F

CAAAAGCGATCACAAAAGCA

This Study

VP1686R

AGCGACTTAACGGCATCATC

This Study

VP1689F

AAGGTTGGCAAAAAGCGTTA

This Study

VP1689R

GCTCTTCAACGAGCCAAGAG

This Study

VP1694F

ACGATGCGACCAACAGTGTA

This Study

VP1694R

TTTTAATTGCATCGGTGACG

This Study

VPA1327F

TGGCGAAAGAGCCATTAGAT

This Study

VPA1327R

TCAACTCCAAATTCGCCTTC

This Study

VPA1335F

ATGTAACGGCGGCTAGCTTA

This Study

VPA1335R

CAAACTGTGTCAGTAGCACCA

This Study
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VPA1339F

GATTCGCGGAACTCAAGAAG

This Study

VPA1339R

CTTGTCCGAGATCAACGTCA

This Study

VPA1346F

GGCTCTGATCTTCGTGAA

This Study

VPA1346R

GATGTTTCAGGCAACTCTC

This Study

VPA1354F

AATTGGCCGAGCCAACTTT

This Study

VPA1354R

GTCATCCGGTTCTTGTGTAA

This Study

VPA1362F

CTGCAGGTATCGCATCTTCA

This Study

VPA1362R

TTAGAACCAACCGACGAAGC

This Study

Beta_vscC2_F

GTACTTTGCTGTCTAACC

(58)

Beta_vscC2_R

CTTACTCTTAACTTCCGACG

(58)

Beta_vscS2_F

TTGATGTTGTTTCGGCTAGC

(58)

Beta_vscS2_R

CCACCGCCGAACTCGGCTAACAAG

(58)

Beta_vopB2_F

GAGCCTGTTGCTCTATGGAGCCAGG

(58)

Beta_vopB2_R

CGACACAGAACGCAATGCTTGCTCG

(58)

Beta_vopC_F

AACCAACTTGCGACTAAATC

(58)

Beta_vopC_R

TCCCGACAGTTTTTCTGCAC

(58)

GS-PCR_F

TAATGAGGTAGAAACA

(43)

GS-PCR_R

ACGTAACGGGCCTACA

(43)
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APPENDIX B
VIBRIO PARAHAEMOLYTICUS ISOLATES USED IN CYTOTOXICITY AND
HEMOCYTE BACTERICIDAL ASSAYS
Isolate Storage Code

tlh

tdh

trh

environmental/clinical

AK strain

+

+

+

clinical

BAA-238

+

+

+

clinical

F11

+

+

+

clinical

Vp2007-095

+

+

+

clinical

Vp2006-016

+

+

+

environmental

Vp2007-023

+

+

+

environmental

Vp2007-052

+

+

+

environmental

Vp2007-057

+

+

+

environmental

Vp2009-015

+

+

+

environmental

Vp2009-026

+

+

+

environmental

Tx2103

+

+

-

clinical

CT6636

+

+

-

clinical

Vp2006-001

+

+

-

environmental

Vp2006-004

+

+

-

environmental

Vp2006-008

+

+

-

environmental

Vp2006-041

+

+

-

environmental

Vp2007-064

+

+

-

environmental

Vp2007-070

+

+

-

environmental

Vp2007-106

+

+

-

environmental

Vp2009-027

+

+

-

environmental

70
AQ4037

+

-

+

clinical

KCHD 613

+

-

+

clinical

Vp2007-005

+

-

+

environmental

Vp2007-007

+

-

+

environmental

Vp2007-025

+

-

+

environmental

FIHES

+

-

-

clinical

901128

+

-

-

clinical

NY3547

+

-

-

clinical

Vp2006-009

+

-

-

environmental

Vp2007-004

+

-

-

environmental

Vp2007-017

+

-

-

environmental

Vp2007-026

+

-

-

environmental
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APPENDIX C
GENES SIGNIFICANTLY UP OR DOWN-REGULATED IN VP OYSTER
HEMOCYTE AND CACO-2 CHALLENGES
Locus

Gene Name

VPA0478
VP2542
A79_5812 ruvB
VP2628
VPA0223
VPA0223
VP0535
lspA
A79_0503
VPA0409
A79_4324
A79_5698
VP0728
VPA0370
VPA0393
VPA0557
VPA0945
VPA0946
VPA0946
VPA1284
VPA1470
VPA1711
A79_3171
VP1211
A79_2580 proB

Description
Tx2103 – Oyster – Down-regulated
putative oxidoreductase
quinone oxidoreductase
holliday junction DNA helicase RuvB
membrane-bound lytic murein transglycosylase C
putative HlyD family secretion protein
putative HlyD family secretion protein
signal peptidase II
potassium uptake protein, TrkH family
plasma membrane protein involved in salt tolerance
Flp pilus assembly protein
RDD family, putative
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
protein YgiW
sensor histidine kinase
glutamate 5-kinase

A79_5012
A79_5726
VP0442
VP0739
VP1143
VP1591
VP2269
VP2433
VP2550
recA

Tx2103 – Oyster – Up-regulated
glycerol-3-phosphate dehydrogenase [NAD(P)+]
(NAD(P)H-dependent glycerol-3-phosphate
dehydrogenase)
ribosomal protein L13
ubiquinol-cytochrome c reductase, cytochrome b
ribose-phosphate pyrophosphokinase
imidazole glycerol phosphate synthase subunit HisF
3-hydroxydecanoyl-ACP dehydratase
succinyl-diaminopimelate desuccinylase
purine nucleoside phosphorylase
recombinase A

72

VP2832
gpsA
VP2880
VP3027
VPA1012
VPA1121
VPA1122
VPA1122
A79_0469
VP0474
VP0752
VP0836
VP1131
VP1377
VP1415
VP1714
VP2025
VP2161
VPA1149
VPA1465
A79_3585
VC1273
VP1597
A79_3591
A79_3591
VP2869
VP2869
VPA0166
VP0778
VP0778
VPA1533

NAD(P)H-dependent glycerol-3-phosphate
dehydrogenase
acetyl-CoA carboxylase
thiamine biosynthesis protein ThiC
cytochrome c554
putative acyl-CoA dehydrogenase
putative aldehyde dehydrogenase
putative aldehyde dehydrogenase
conserved hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
cyclic nucleotide binding protein/2 CBS domains
extracellular solute-binding protein, family 7
putative N6-adenine-specific DNA methylase
sodium/solute symporter, putative
sodium/solute symporter, putative
sodium/solute symporter
sodium/solute symporter
putative outer membrane protein
flagellar hook protein
flagellar hook protein
putative flagellum-specific ATP synthase

A79_0634
A79_0994 ectA
A79_1067
A79_1166
A79_1298
A79_1741
A79_1923
A79_2025
A79_2026
A79_3791 oadA
A79_4400

Tx2103 – Caco-2 – Down-regulated
lactaldehyde reductase
L-2,4-diaminobutyric acid acetyltransferase
citrate synthase
sulfatase
probable 6-phospho-beta-glucosidase
endonuclease/exonuclease/phosphatase family
deCa-heme c-type cytochrome
translation elongation factor
mandelate racemase
oxaloacetate decarboxylase alpha subunit
Zn-dependent protease
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A79_4475 cydB
A79_4818
A79_4898
A79_5364
A79_6218
VCA0859
VP0028
VP0482
VP0748
VP2444
VP2461
VPA0102
VPA0958
VPA0984
VPA1129
VPA1147
VPA1411
A79_1306
A79_1516
A79_1943
A79_4920
A79_5405
A79_6125
VP0474
VP0625
VP0626
VP0989
VP1223
VP1939
VP2341
VP2421
VPA0137
VPA0140
VPA0837
VPA1031
VPA1074
VPA1146
A79_2291
A79_3690
A79_4210 pcm
A79_4578
VP0122
VPA0335

cytochrome D ubiquinol oxidase, subunit II
chromosome partition protein MukB
acetyltransferase, gnat family
endochitinase
NADP-dependent fatty aldehyde dehydrogenase
oxidoreductase, aldo/keto reductase 2 family
zinc-binding alcohol dehydrogenase
glutamate synthase, large subunit
5'-nucleotidase precursor
putative acetyltransferase
phosphoglucomutase/phosphomannomutase family protein
MrsA
putative isomerase
putative NADH oxidase
uroporphyrin-III C-methyltransferase
putative hydroxymethylglutaryl-CoA lyase
putative phenylacetate-CoA ligase
putative glycosyltransferase
conserved hypothetical protein
conserved hypothetical protein
conserved hypothetical protein
conserved hypothetical protein
conserved hypothetical protein
conserved hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
transmembrane regulatory protein ToxS
transcriptional regulator
protein-L-isoaspartate O-methyltransferase
methyltransferase
BipA protein
SoxR protein
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VPA1497
VPA1655
A79_1508
A79_2318
A79_3700
VP0415
VP0660
VP0702
VP1218
VP1435
VP2702
VPA0154
VPA0604
VPA1166
A79_2667
A79_3151
VPA1329

transcriptional regulator, LysR family
putative FecB
ABC transporter, permease/ATP-binding protein
putative sugar transport system
multidrug resistance protein A
putative general secretion pathway protein A
putative type IV pilin
SecY interacting protein Syd
putative outer membrane protein precursor
putative sodium/glutamate symporter
MSHA biogenesis protein MshN
TonB system transport protein ExbD2
ABC transporter, periplasmic substrate-binding protein
chloride channel protein
polar flagellin A
putative biofilm-associated surface protein
putative traA protein

A79_0026
A79_0678
A79_1359 argG
A79_1778
A79_1855
A79_2942
A79_3490
A79_3675
A79_4878
A79_5231
A79_5242
A79_5484
A79_6050
A79_6198 hmgA
VP0041
VP0157
VP0481
VP0513
lysS
VP0665
VP0716
VP0722
VP1255
VP1301
VP2322
VP2400

Tx2103 – Caco-2 – Up-regulated
chitobiase
ABC transporter, ATP-binding protein
argininosuccinate synthase
UTP--glucose-1-phosphate uridylyltransferase
glutaredoxin
translation initiation factor IF-2
ImcF-related family
glutathione peroxidase
amidohydrolase 3
prolipoprotein diacylglyceryl transferase
thiol:disulfide interchange protein DsbC
conserved hypothetical protein
cell wall-associated hydrolase
homogentisate 1,2-dioxygenase
ATP-dependent DNA helicase Rep
ATP-dependent DNA helicase RecG
glutamate synthase, small subunit
lysyl-tRNA synthetase
transglycosylase, Slt family
lipoyl synthase
penicillin-binding protein 2
GGDEF family protein
exodeoxyribonuclease I
pseudouridine synthase Rlu family protein
UDP-glucose 4-epimerase
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VP2861
VP2911
VP2942
VP3000
rho
VPA0123
VPA0124
VPA0436
VPA0474
VPA0566
VPA1201
A79_0571
A79_0584
A79_0604
A79_1952
A79_3581
A79_3692
A79_4983
VCA0645
VP0473
VP1559
VP1683
VP2085
VP2172
VP2774
VP2905
VPA0005
VPA0056
VPA0418
VPA0749
VPA0787
VPA0933
VPA0933
VPA1344
VPA1426
VPA1743
A79_0525
A79_1659
A79_5786
VP0569
VP0833
fur
VP2574
VP2857
A79_0499
A79_1271

rRNA methylase, SpoU family
DNA-binding protein HU-2
soluble pyridine nucleotide transhydrogenase
transcription termination factor Rho
putative hydrolase
putative acetyltransferase
putative resolvase
spermidine n1-acetyltransferase
alcohol dehydrogenase
periplasmic nitrate reductase, cytochrome c-type protein
hypothetical protein
conserved hypothetical protein
conserved hypothetical protein
conserved hypothetical protein
conserved hypothetical protein
conserved hypothetical protein
conserved hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
CpsF
protein YhgF
sensory box/ggdef family protein
DNA-binding response regulator PhoB
ferric uptake regulator
GTP-binding protein LepA
putative periplasmic protein CpxP
ABC-type multidrug efflux pump
outer membrane protein
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A79_1552
A79_1627
A79_1684 putP
A79_2015
VPA0721
VPA0856
A79_1849
VPA1539
VPA1541
A79_3703
VPA1218

putative msha pilin protein msha
amino-acid abc transporter binding protein
sodium/proline symporter
outer membrane protein
rough colony protein RcpA
putative transmembrane transport protein
methyl-accepting chemotaxis protein
putative sodium-type flagellar protein MotY precursor
flagellar motor switch protein
autoinducer 2 sensor kinase/phosphatase LuxQ
putative secretion protein

A79_0425
A79_2680
A79_3664
A79_4129
A79_4272
A79_5966
A79_5966
VP1103
VP2428
VP2434
VP2948
VP2953
VPA0169
VP0187
VP0219
VP0254
VP1041
VP2469
VP3030
VPA1284
A79_2408
A79_4778
VP2577
VP2772
VPA1538
VP0535
VP1194
VP2676
VPA0318
VPA0318
VPA1533

AQ4037 – Oyster – Down-regulated
2-amino-3-ketobutyrate coenzyme A ligase
lipoprotein-34 NlpB
sulfatase
PhoH family protein
protein ThiJ
pyruvate kinase
pyruvate kinase
alanine dehydrogenase
elongation factor EF-2
phosphopentomutase
4-hydroxybenzoate octaprenyltransferase
RNA polymerase sigma factor 32
agmatinase
putative Dca
hypothetical protein
hypothetical protein
gonadoliberin III-related protein
hypothetical protein
hypothetical protein
hypothetical protein
GTP-binding protein Obg/CgtA
transcriptional regulatory protein FixJ
sigma-E factor negative regulatory protein RseA
30S ribosomal protein S7
putative two-component response regulator
signal peptidase II
putative ABC transporter, ATP-binding protein
PmbA protein
putative outer membrane protein OmpV
putative outer membrane protein OmpV
putative flagellum-specific ATP synthase

kbl

pyk
pyk

rseA
rpsG
lspA
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VPA0423

AQ4037 – Oyster – Up-regulated
vibrioferrin biosynthesis protein PvsA
redoxin domain protein
smr/muts family protein
ATP-dependent Clp protease, ATP-binding subunit ClpA
30S ribosomal protein S2
UTP-glucose-1-phosphate uridylyltransferase
30S ribosomal protein S3
lactonizing lipase
3-hydroxydecanoyl-ACP dehydratase
acyl carrier protein
fumarate hydratase
fumarate hydratase
putative DNA-binding stress protein
2-amino-3-ketobutyrate coenzyme A ligase
putative AcsD
conserved hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
putative LicD1 protein
hypothetical protein
hypothetical protein
hypothetical protein
transcriptional regulator, MarR family
YheO domain protein
cyclic nucleotide binding protein/2 CBS domains
RNA polymerase sigma factor 32 (RpoS)
putative LysR-family transcriptional regulator
rod shape-determining protein MreB
transcriptional regulator, LacI family
peptide transport system ATP-binding protein SapF
putative ABC transporter substrate-binding protein
hemin ABC transporter, periplasmic hemin-binding
protein HutB

A79_0177 metC
A79_0319
A79_0891
A79_1711

AQ4037 – Caco-2 – Down-regulated
cystathionine beta-lyase
RNA pseudouridine synthase family protein
acetyltransferase
phospholipase, patatin family

A79_3197
A79_4687
A79_6044
VC1144
VC2260
VP0237
VP0263
rpsC
VP1181
VP1591
VP2053
VP2873
fumC
VP2873
fumC
VPA0454
VPA1510
VPA1661
A79_4798
VC1778
VP0595
VP0752
VP0752
VP0836
VP1322
VP2328
VP2424
VPA1330
A79_0955
A79_3059
A79_3585
A79_4208
A79_4376
VC0415
VP2632
A79_0162
VPA0133
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A79_1845
A79_2269
A79_2810
A79_3146
A79_3363
A79_4285
A79_4432
VC0305
VP0033
VP0735
VP0829
VP1048
ruvC
VP1301
VP1646
VP2186
VP2316
VP2552
VP2885
VP3035
VPA0278
VPA0867
VPA1158
VPA1201
A79_0377
A79_0876
A79_1669
A79_1851
A79_2215
A79_2446
A79_2553
A79_4489
A79_4496
A79_4782
A79_5417
A79_5997
VCA1065
VP0913
VPA0443
VPA0720
VPA0748
VPA0772
VPA1027
VPA1092

efflux ABC transporter, permease protein
glycosyl transferase, family 39
4-aminobutyrate aminotransferase
oxidoreductase alpha (molybdopterin) subunit
khg/kdpg aldolase
tellurite resistance protein
ferredoxin-dependent glutamate synthase 1
ATP-dependent RNA helicase
protoporphyrinogen oxidase
2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol
hydroxylase
N-acetylglucosamine-6-phosphate deacetylase
Holliday junction resolvase
exodeoxyribonuclease I
aconitate hydratase
bacteriocin production protein
uridylate kinase
DNA mismatch repair protein
DNA-binding protein Fis
Sua5/YciO/YrdC family protein
isopentenyl pyrophosphate isomerase
DnaJ-related protein
acetyl-CoA synthase
periplasmic nitrate reductase, cytochrome c-type protein
YjqA
conserved hypothetical protein
conserved hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
conserved hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
conserved hypothetical protein
conserved hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
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VPA1599
VPA1692
A79_0638
A79_1285
A79_4639
A79_5987
VCA0682
VP1755
A79_1439
A79_3159
A79_3605
A79_3675
A79_3727 napD
A79_4966
VP3066
VPA0153
VPA0650
VPA0721 rcpA
VPA1131
VP1535
uspE
VP2159
VP2254
VPA1554
VPA0939
VPA1307
A79_0585
A79_2095
A79_0426
A79_1191
A79_1643
A79_2228
A79_2276
A79_3168
A79_4292
A79_4687
A79_5041
A79_5105
A79_5288
A79_5815
A79_5816
A79_6062

hypothetical protein
hypothetical protein
transcriptional regulator, AraC family
protein in PtsN-ptsO intergenic region
two-component response regulator
twin-arginine translocation pathway signal
transcriptional regulator UhpA
putative histidine kinase
permease of the drug/metabolite transporter
cation efflux system
MadN protein
glutathione peroxidase
NapD protein
permease of the major facilitator superfamily
putative amino acid ABC transporter, permease protein
TonB system transport protein ExbB2
heat shock protein 70 family protein
rough colony protein RcpA
putative periplasmic binding protein-related protein
putative stress protein
putative methyl-accepting chemotaxis transmembrane
protein
flagellar protein FliS
LafF
putative adhesin
putative adhesion protein
VcsR2
type IV pilus assembly protein PilZ

AQ4037 – Caco-2 – Up-regulated
tdh
L-threonine 3-dehydrogenase
moaD molybdopterin converting factor, subunit 1
pfkA 6-phosphofructokinase
polyribonucleotide nucleotidyltransferase
DNA gyrase/topoisomerase IV, A subunit
ATP-dependent Zn protease
glpK glycerol kinase
redoxin domain protein
menB naphthoate synthase
mobA molybdopterin-guanine dinucleotide biosynthesis protein A
soluble lytic murein transglycosylase
ruvC crossover junction endodeoxyribonuclease RuvC
aspS
aspartyl-tRNA synthetase
isocitrate dehydrogenase, NADP-dependent
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A79_6250
A79_6262
VC2260
VP0152
VP0202
VP0231
VP0507
VP0846
VP1533
VP1542
VP1591
VP1591
VP1724
VP2055
VP2055
VP2056
VP2071
VP2096
VP2194
VP2273
VP2326
VP2326
VP2342
VP2355
VP2437
VP2599
VP2676
VPA0263
VPA0436
VPA0452
VPA0466
VPA0611
VPA0618
VPA0648
VPA1157
VPA1498
A79_0469
A79_0469
A79_0903
A79_1374
A79_1810
A79_2007
A79_4386
A79_4827

purT
greB

sdhB

dapA

tldE

phosphoribosylglycinamide formyltransferase 2
endonuclease 4
30S ribosomal protein S2
transcription elongation factor GreB
putative sugar-phosphate nucleotide transferase
putative UDP-galactose phosphate transferase
branched chain amino acid transport system II carrier protein
succinate dehydrogenase catalytic subunit
putative ATPase
cytochrome c oxidase, subunit CcoQ
3-hydroxydecanoyl-ACP dehydratase
3-hydroxydecanoyl-ACP dehydratase
DNA polymerase III subunit epsilon
acyl carrier protein S-malonyltransferase
acyl carrier protein S-malonyltransferase
3-oxoacyl-(acyl carrier protein) synthase
fatty acid metabolism regulator
molybdenum cofactor biosynthesis protein A
3-oxoacyl-[acyl-carrier-protein] synthase I
dihydrodipicolinate synthase
acetyltransferase-related protein
acetyltransferase-related protein
DNA polymerase IV
peptidyl-prolyl cis-trans isomerase A
NupC family protein
fructose-bisphosphate aldolase
PmbA protein (peptidase)
flagellar basal body P-ring biosynthesis protein
putative resolvase
putative cytochrome b561
universal stress protein A
acetate/propionate kinase
putative acyl-CoA dehydrogenase
putative DOPA-dioxygenase-related protein
electron transfer flavoprotein, alpha-subunit
putative L-lactate permease
conserved hypothetical protein
conserved hypothetical protein
conserved hypothetical protein
Hypothetical - FOG ggdef domain
conserved hypothetical protein
conserved hypothetical protein
conserved hypothetical protein
Hypothetical - gonadoliberin III-related protein
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VC1685
VCA0645
VCA0967
VP0039
VP0595
VP0749
VP0898
VP0901
VP0937
VP0943
VP1518
VP1659
VP1803
VP2421
VP2789
VP2850
VP2905
VP3049
VPA0039
VPA0156
VPA0206
VPA0219
VPA0324
VPA0406
VPA0451
VPA0499
VPA0521
VPA0652
VPA0934
VPA1352
A79_2612
A79_4974
VP0899
VP1101
VP1130
VP1734
VP2793
VP2824
VP3067
VPA1276
VPA1655
A79_0144
A79_2413

cysB

glmU

hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical lipoprotein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
SpoOM-related protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical adenine-specific methylase YfcB
AraC-type DNA-binding domain-containing protein
putative O-methyltransferase
transcriptional regulator for cysteine regulon
tRNA (5-methylaminomethyl-2-thiouridylate)-methyltransferase
DNA-binding response regulator
cyclic AMP receptor protein
ribosome-associated GTPase
bifunctional N-acetylglucosamine-1-phosphate
uridyltransferase/glucosamine-1-phosphate acetyltransferase
putative DNA-binding response regulator
putative FecB
ABC-type multidrug efflux pump
ApaG protein
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A79_2622
A79_2788
A79_3241
A79_4905
VC1361
VP0507
VP1180
VP1879
VP1998
VP2091
VP3069
VPA0150
A79_1856
A79_2645
A79_3959
A79_6092
VP2230
A79_0745
VP1656

brnQ

flhB

long-chain fatty acid transport protein
magnesium and cobalt efflux protein CorC
putative alkylphosphonate ABC tranporter
branched-chain amino acid transport system II carrier protein
amino acid ABC transporter, permease protein
branched chain amino acid transport system II carrier protein
lipase chaperone
serine transporter
putative outer membrane protein TolC
oligopeptide ABC transporter, periplasmic oligopeptide-binding protein
ATP synthase subunit B
putative ferrichrome-iron receptor
putative protein F-related protein
flagellar biosynthetic protein FlhB
FlgE
flagellar biosynthesis protein FlhF
chemotaxis protein CheZ
putative biofilm-associated surface protein
putative translocator protein PopD
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VPA1419
VPA1510
VP2542
VPA1152
VP3027
VP0540
VP3019
VP0540
A79_2779
VP3027
A79_2782
VP3023
A79_2777
A79_2779
A79_2782
VP3022
VP3022
A79_2777
VP3023
VP3025
VP3025
VP3024
VP3024
VPA0223
VC1565
VP3019
A79_2785
VPA1303
VPA0945
A79_4386
VP1581
VP1076
VPA0438
VPA0946
VPA0946
VPA0960
VPA0947

cstA
cstA
thiF
thiH
thiG
thiC
thiF
thiH
thiC
thiG

Higher in Tx2103 – 1h – Oys
putative 3-hydroxyisobutyrate dehydrogenase
2-amino-3-ketobutyrate coenzyme A ligase
quinone oxidoreductase
putative long-chain-fatty-acid-CoA ligase
thiamine biosynthesis protein ThiC
putative carbon starvation protein A
putative multidrug resistance protein
putative carbon starvation protein A
thiazole biosynthesis adenylyltransferase ThiF
thiamine biosynthesis protein ThiC
thiazole biosynthesis protein ThiH
thiazole synthase
thiamine biosynthesis protein ThiC
thiazole biosynthesis adenylyltransferase ThiF
thiazole biosynthesis protein ThiH
thiamine biosynthesis protein ThiH
thiamine biosynthesis protein ThiH
thiamine biosynthesis protein ThiC
thiazole synthase
ThiF protein
ThiF protein
sulfur carrier protein ThiS
sulfur carrier protein ThiS
putative HlyD family secretion protein
outer membrane protein TolC, putative
putative multidrug resistance protein
permease of the major facilitator superfamily
hypothetical protein
hypothetical protein
conserved hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
transcriptional regulator, ArsR family
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A79_0425 kbl
A79_4236
A79_4181
A79_0278
VP3054
A79_1369 cadA
VPA1533
A79_3632
VPA0339
VP0474

A79_5012
A79_3065
VP2434
A79_4272
VPA1163
VC0067
VP0442
VP2880
A79_5726
VP0739
VPA1126
VPA1122
VPA0301
VPA1419
VP3026
VP2869
VPA1121
VPA1122
A79_3591
VPA1157
VPA1230
VPA1121
VP3026
VP1281
VP2030
VPA1152
VP3027
VP3027

Higher in AQ4037 – 1h – Oys
2-amino-3-ketobutyrate coenzyme A ligase
putative efflux pump component MtrF
outer membrane phospholipase, chain A
helicase IV
thiol:disulfide interchange protein
cadmium-translocating P-type ATPase
putative flagellum-specific ATP synthase
polar flagellin
hypothetical protein
hypothetical protein

Higher in Tx2103 – 4h – Oys
glycerol-3-phosphate dehydrogenase [NAD(P)+]
(NAD(P)H-dependent glycerol-3-phosphate
dehydrogenase)
lactoylglutathione lyase
phosphopentomutase
protein ThiJ
oxidoreductase, aldo/keto reductase 2 family
aminopeptidase P
ubiquinol-cytochrome c reductase, cytochrome b
acetyl-CoA carboxylase
ribosomal protein L13
ribose-phosphate pyrophosphokinase
putative acyl-CoA carboxyltransferase beta chain
putative aldehyde dehydrogenase
methionine sulfoxide reductase A
putative 3-hydroxyisobutyrate dehydrogenase
thiamine-phosphate pyrophosphorylase
sodium/solute symporter
putative acyl-CoA dehydrogenase
putative aldehyde dehydrogenase
sodium/solute symporter, putative
electron transfer flavoprotein, alpha-subunit
glyceraldehyde-3-phosphate dehydrogenase
putative acyl-CoA dehydrogenase
thiamine-phosphate pyrophosphorylase
rpmI 50S ribosomal protein L35
30S ribosomal protein S1
putative long-chain-fatty-acid-CoA ligase
thiamine biosynthesis protein ThiC
thiamine biosynthesis protein ThiC
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VPA1120
A79_2782
VP3023
VP3023
VP3022
VP0540
VP3022
A79_2782
VP0540
VP3025
A79_2777
VP3025
A79_2777
A79_3579
A79_6073
VP2867
VP1966
VP1194
VP3019
VPA0166
VPA1542
VP2161
VP0304
A79_3629
VP0304
VP1795
VPA0960
VPA0960
A79_4778
VP2386

thiH
thiG
thiG

thiH
thiC
thiC
treP

enoyl-CoA hydratase
thiazole biosynthesis protein ThiH
thiazole synthase
thiazole synthase
thiamine biosynthesis protein ThiH
putative carbon starvation protein A
thiamine biosynthesis protein ThiH
thiazole biosynthesis protein ThiH
putative carbon starvation protein A
ThiF protein
thiamine biosynthesis protein ThiC
ThiF protein
thiamine biosynthesis protein ThiC
pts system, trehalose-specific iibc component
amino acid ABC transporter, permease protein
cell volume regulation protein CvrA
proton/glutamate symporter
putative ABC transporter, ATP-binding protein
putative multidrug resistance protein
putative outer membrane protein
putative flagellar assembly protein
hypothetical protein
hypothetical protein
single-strand binding protein family
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
transcriptional regulatory protein FixJ
glycerol kinase

Higher in AQ4037 – 4h – Oys
VCA0563 pntA NAD(P) transhydrogenase subunit alpha
VPA0453
catalase/peroxidase
VPA0454
putative DNA-binding stress protein
VP1181
lactonizing lipase
VP2704
MSHA biogenesis protein MshL
VPA0793
hypothetical protein
A79_2118
conserved hypothetical protein
VC1530
hypothetical protein
A79_5433
conserved hypothetical protein
A79_4798
conserved hypothetical protein
VP0761
hypothetical protein
A79_2478
ParA family protein
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VPA0345
VPA0690
VPA0397
VP1870
VPA0036
A79_4381
A79_2580 proB
VP3061
A79_0698
A79_4609
A79_2276
VPA1055
A79_2318
VP1903
VP0710
VP1450
A79_4818
A79_4475
A79_5288
VP1468
A79_6250
A79_6218
VPA0452
VP3007
VPA1155
VP1112
A79_6250
VP1724
VPA0192
VPA1674
A79_1169
VP0088
VPA0691
VPA1157
VP3022
VP0260
VP3022
VP3027
VP3025
VP3027
VP3025
VPA0489

ilvB

cydB
purT

purT

nhaB

hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
transcriptional regulator
glutamate 5-kinase
Higher in Tx2103 – 1h – Caco-2
dihydroxy-acid dehydratase
STM-proteaseA
acetolactate synthase, large subunit, biosynthetic type
DNA gyrase/topoisomerase IV, A subunit
nitrite reductase
putative sugar transport system
DNA polymerase III subunit epsilon
PTS system, trehalose-specific IIBC component
putative component of anaerobic dehydrogenase
chromosome partition protein MukB
cytochrome D ubiquinol oxidase, subunit II
soluble lytic murein transglycosylase
putative hexosyltransferase
phosphoribosylglycinamide formyltransferase 2
NADP-dependent fatty aldehyde dehydrogenase
putative cytochrome b561
ATP-dependent DNA helicase RecQ
electron transfer flavoprotein-ubiquinone oxidoreductase
adenosylmethionine--8-amino-7-oxononanoate transaminase
phosphoribosylglycinamide formyltransferase 2
DNA polymerase III subunit epsilon
tryptophanase
ribulokinase
Na+/H+ antiporter NhaB
hypothetical protein
putative riboflavin deaminase
electron transfer flavoprotein, alpha-subunit
thiamine biosynthesis protein ThiH
50S ribosomal protein L2
thiamine biosynthesis protein ThiH
thiamine biosynthesis protein ThiC
ThiF protein
thiamine biosynthesis protein ThiC
ThiF protein
putative ATP-binding component of a transport system
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VPA0488
VP2310
VP1526
VPA0352
A79_5938
A79_0269
VCA0758
A79_2667
VP2693
VP0122
VPA1349
VP0660
pilV
A79_0729 pilP
A79_2291
VP2024
VPA0137
VP1571
A79_2830
VPA0652
VPA0850
VPA0165
VP1733
VP2376
A79_5479
VPA1305
VC1685
VPA1655
A79_3927
VP0586
VP1533
VP2278
VP0595
VP0554
A79_2612
A79_4974
A79_4210 pcm
VP0428
A79_4578
VPA1279
VP1786
A79_0458
VP1939
VP0368

putative transmembrane protein
surface antigen (outer membrane protein assembly factor YaeT)
spermidine/putrescine ABC transporter, periplasmic spermidine/putrescinebinding protein
putative permease of ABC transporter
drug resistance transporter, EmrB/QacA family
transporter
arginine ABC transporter, permease protein
polar flagellin A
putative MshP protein
BipA protein
putative Type III secretion protein Spa33
putative type IV pilin
type IV pilus
transmembrane regulatory protein ToxS
hypothetical protein
hypothetical protein
hypothetical protein
conserved hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
putative FecB
conserved hypothetical protein
hypothetical protein
putative ATPase (bacteriophage f237 ORF3)
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical adenine-specific methylase YfcB
AraC-type DNA-binding domain-containing protein
protein-L-isoaspartate O-methyltransferase
cyclic AMP phosphodiesterase
methyltransferase
diacylglycerol kinase
hypothetical protein
transposase
hypothetical protein
mannitol operon repressor
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VP2927
VP2294

nusG

transcription antitermination protein NusG
putative SAM-dependent methyltransferase

Higher in AQ4037 – 1h - Caco-2
A79_4492
acyl-CoA dehydrogenase
VP1036
mukE condesin subunit E
A79_1684 putP sodium/proline symporter
A79_3675
glutathione peroxidase
VP1771
4-aminobutyrate aminotransferase
VPA0642
putative glutathione S-transferase
VPA1201 napC periplasmic nitrate reductase, cytochrome c-type protein
A79_6380
ferredoxin
VP1348
peptidase, M20A family
VC0305
RhlB ATP-dependent RNA helicase
1-(5-phosphoribosyl)-5-[(5- phosphoribosylamino)methylideneamino]
VP1142
imidazole-4-carboxamide isomerase
A79_2711
nuclease
VP2032
sohB sohB protein, peptidase U7 family
VP0665
transglycosylase, Slt family
A79_3669
oxidoreductase, short-chain dehydrogenase/reductase family
A79_2292
adenylosuccinate synthetase
A79_1359 argG argininosuccinate synthase
VP0722
penicillin-binding protein 2
A79_1372
ferredoxin-1
A79_1694
permease of the drug/metabolite transporter
A79_1439
permease of the drug/metabolite transporter
VP1216
multidrug resistance protein (bicyclomycin/multidrug efflux pump)
VP2411
putative tight adherence TadB-related transmembrane protein
VP0706
ABC transporter, ATP-binding protein
A79_3190
methyl-accepting chemotaxis protein
VPA1541
flagellar motor switch protein
VP2811
sodium-type polar flagellar protein MotX
A79_3703
autoinducer 2 sensor kinase/phosphatase LuxQ
A79_1552
putative msha pilin protein msha
VP1657
putative translocator protein PopB
A79_3165
putative adhesin
VPA1218
putative secretion protein
VPA0442
hypothetical protein
VPA0061
hypothetical membrane protein
VPA0772
hypothetical protein
A79_0377
YjqA
VP0668
hypothetical protein
A79_5572
conserved hypothetical protein
A79_0244
conserved hypothetical protein
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VPA0787
A79_0876
VPA0749
A79_5417
VC1530
VP1509
A79_4782
VP2085
A79_4983
VP1918
A79_5484
A79_1374
VPA1426
A79_5997
A79_2935 rpoN
VPA0619
VP2450
A79_5786
VP1016
infA
A79_5987
A79_1855
VP3000
rho
VP2109
VP1468
A79_0891
A79_4217 pyrG
VP1719
VP2431
A79_1778
A79_0698
A79_1659
VP1781
VP0596
VP2316
VP2322
A79_4485
VP0826
asnB
VP1215
VC2090
A79_5302 pdhA
A79_2854 fni

hypothetical protein
conserved hypothetical protein
hypothetical protein
conserved hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
conserved hypothetical protein
hypothetical protein
conserved hypothetical protein
FOG ggdef domain
hypothetical protein
conserved hypothetical protein
RNA polymerase sigma-54 factor
putative transcriptional regulator
transcriptional regulator, MarR family
sensory box/ggdef family protein
translation initiation factor IF-1
twin-arginine translocation pathway signal
glutaredoxin
transcription termination factor Rho
Higher in Tx2103 – 4h – Caco-2
lactoylglutathione lyase
putative hexosyltransferase
acetyltransferase
CTP synthase
aspartate kinase
phosphoserine phosphatase
UTP--glucose-1-phosphate uridylyltransferase
STM-proteaseA
protein YhgF
putative glutamine synthetase
cysteine desulfurase
uridylate kinase
pseudouridine synthase Rlu family protein
enoyl-CoA hydratase/carnithine racemase
asparagine synthetase B
ribosomal small subunit pseudouridine synthase A
succinate dehydrogenase, hydrophobic membrane anchor
protein
pyruvate dehydrogenase E1 component, alpha subunit
isopentenyl-diphosphate delta-isomerase, type 2
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VP3059
VPA1201
VP0408
VCA1060
A79_1193
VPA0409
A79_3171
A79_1946
VP1916
VPA0305
VC2402
VP1646
A79_0795
VP1275
VP1646
VP1301
A79_0865
A79_6240
A79_6198
VP3022
A79_2782
VP3022
VP3025
VP3025
VP3024
VC1273
A79_2015
A79_1549
A79_3159
A79_2430
VP1511
VP2329
VP3066
VP1474
VPA0721
VP0170
VP2746
VP2247
VPA1492
VPA1539
VPA0939
A79_6356
A79_1885
A79_0585

acetolactate synthase II, small subunit
periplasmic nitrate reductase, cytochrome c-type protein
O-sialoglycoprotein endopeptidase
ribB
3,4-dihydroxy-2-butanone 4-phosphate synthase
moaB molybdenum cofactor biosynthesis protein B
plasma membrane protein involved in salt tolerance
protein YgiW
phosphotransferase family protein
putative amidase
catalase
cell division protein FtsW
aconitate hydratase
collagenase PrtC
formimidoylglutamase
aconitate hydratase
exodeoxyribonuclease I
stability protein StbD, putative
bifunctional adenosylcobalamin biosynthesis protein CobP
hmgA homogentisate 1,2-dioxygenase
thiamine biosynthesis protein ThiH
thiH
thiazole biosynthesis protein ThiH
thiamine biosynthesis protein ThiH
ThiF protein
ThiF protein
sulfur carrier protein ThiS
extracellular solute-binding protein, family 7
outer membrane protein
rarD
RarD protein
cation efflux system
tolQ
protein TolQ
putative formate dehydrogenase-specific chaperone
efflux pump component MtrF
putative amino acid ABC transporter, permease protein
putative capsule transport protein, OtnA protein
rough colony protein RcpA
putative transmembrane ABC transporter protein
fimbrial assembly protein
flagellar assembly protein
methyl-accepting chemotaxis protein
putative sodium-type flagellar protein MotY precursor
putative adhesin
msha biogenesis protein mshe
ggdef family protein
VcsR2
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A79_5997
A79_0481
A79_2427
A79_3927
VPA0204
A79_4496
A79_2032
VCA1065
VCA1076
VCA1076
A79_4782
A79_1851
VP2647
A79_6072
VPA0095
VPA0704
A79_4489
VP0888
VPA1305
VP1845
VP1836
VP0670
VP1886
VP0913
VPA1599
A79_1669
VC1530
VP2853
A79_3581
VPA1692
VPA0926
VPA1246
VPA0720
VCA0126
VPA1068
VP2494
VPA0815
VPA1743
A79_0768
A79_2942
VPA0974
VPA0249
A79_0684
A79_1151

conserved hypothetical protein
conserved hypothetical protein
hypothetical protein
conserved hypothetical protein
hypothetical protein
hypothetical protein
conserved hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
conserved hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
conserved hypothetical protein
hypothetical protein
hypothetical protein
conserved hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
Rrf2 family protein
translation initiation factor IF-2
putative AraC-family transcriptional regulatory protein
putative transcription activator
signal transduction histidine kinase
methyltransferase
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VPA0988
VPA1214

nucleoside diphosphate kinase regulator
putative transcriptional regulator

Higher in AQ4037 – 4h – Caco-2
VP2770
tuf
elongation factor Tu
VP0580
antioxidant, AhpC/Tsa family
VP0920
DNA-binding protein HU-beta
VP1879
serine transporter
VP3069
ATP synthase subunit B
VP0251
putative cell division protein FtsN
VP0580
antioxidant, AhpC/Tsa family
A79_4292 glpK glycerol kinase
VP2863
aspartate ammonia-lyase
VP1591
3-hydroxydecanoyl-ACP dehydratase
VP3074
ATP synthase subunit C
VP2863
aspartate ammonia-lyase
VP3070
ATP synthase subunit C
A79_0927
putative transposase B
A79_1499 gcvP glycine dehydrogenase
VP1116
bioD dithiobiotin synthetase
VP0202
putative sugar-phosphate nucleotide transferase
VP2437
NupC family protein
A79_4687
redoxin domain protein
A79_3791 oadA oxaloacetate decarboxylase alpha subunit
VPA0611
acetate/propionate kinase
VP0129
phosphoenolpyruvate carboxykinase
VP1438
DnaK-related protein
VP1944
excinuclease ABC subunit C
A79_3896
T-protein
VP0479
5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase
A79_1971
succinate dehydrogenase flavoprotein subunit
A79_5522
3-oxoacyl-[acyl-carrier-protein] synthase 1
VPA0936
aspartate aminotransferase
A79_6218
NADP-dependent fatty aldehyde dehydrogenase
A79_3257 add
adenosine deaminase
A79_3588
fumarate hydratase class II 1
VP2188
folylpolyglutamate synthase/dihydrofolate synthase
VPA0784 def
peptide deformylase
A79_1741
endonuclease/exonuclease/phosphatase family
A79_6062
isocitrate dehydrogenase, NADP-dependent
A79_5522
3-oxoacyl-[acyl-carrier-protein] synthase 1
A79_1298
probable 6-phospho-beta-glucosidase
A79_2811 phnW 2-aminoethylphosphonate--pyruvate transaminase
A79_0634
lactaldehyde reductase
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A79_3374
VP1730
VP1229
VP0395
VP2351
VPA0102
A79_4898
VP2355
A79_6262
A79_2364
A79_0627
A79_4262
VP1542
VP2032
A79_0994
VPA0618
VP1543
VP1878
VP0483
VP1542
A79_2026
A79_1272
VP1010
VP1586
VPA1395
VPA0813
VPA0060
A79_3232
VP1933
A79_3653
VPA1498
A79_5581
VP1163
VP2091
VP1879
VP0507
VP2642
VPA1704
VP2091
VP1435
A79_4067
A79_2416

ppiB
ectA

spoT
leuA

ATP-dependent DNA helicase rep
putative long-chain-fatty-acid-CoA ligase
Na+/H+-antiporter protein
type I restriction enzyme R protein
Na(+)-translocating NADH-quinone reductase subunit A
putative isomerase
acetyltransferase, gnat family
peptidyl-prolyl cis-trans isomerase A
endonuclease 4
radical SAM protein, family
6-phospho-beta-glucosidase BglA
peptidyl-prolyl cis-trans isomerase B
cytochrome c oxidase, subunit CcoQ
sohB protein, peptidase U7 family
L-2,4-diaminobutyric acid acetyltransferase
putative acyl-CoA dehydrogenase
cytochrome c oxidase, subunit CcoO
MutT/nudix family protein
glutamate synthase, small subunit
cytochrome c oxidase, subunit CcoQ
mandelate racemase
copper/silver resistance periplasmic protein
pseudouridine synthase family 1 protein
putative phage protein, Vpf148 [bacteriophage VfO3K6]
putative transposase
PTS system, fructose-specific IIA/FPR component
lysis protein - phage PP7
guanosine-3,5-bis(diphosphate) 3-pyrophosphohydrolase
3-demethylubiquinone-9 3-methyltransferase
2-isopropylmalate synthase
putative L-lactate permease
cytosol aminopeptidase
putative alpha-1,6-galactosidase
oligopeptide ABC transporter, periplasmic oligopeptide-binding
protein
serine transporter
branched chain amino acid transport system II carrier protein
putative permease
putative integral membrane protein, possible transporter
oligopeptide ABC transporter, periplasmic oligopeptide-binding
protein
putative sodium/glutamate symporter
anaerobic C4-dicarboxylate transporter DcuA
chaperone SurA
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A79_4385
VP0591
VP1995
VP2437
A79_3700
VPA0604
VPA0424
VP2705
VPA0807
VP2258
VP1184
VP2259
VPA0266
A79_1856
VP0773
VP1656
VP1665
A79_1019
VPA1329
VP1656
VP1660
A79_0582
VP1801
A79_3606
VPA0451
VP1257
VPA0196
A79_0600
VPA0371
VPA0837
VP1495
VP2278
VPA1245
VPA0156
VP1269
VP2469
A79_4827
A79_1374
VPA0935
A79_0245
VP2421
A79_1306
VPA1735
VP1238

low-affinity zinc transport protein
protein export protein SecF
ABC transporter, ATP-binding protein
NupC family protein
multidrug resistance protein A
ABC transporter, periplasmic substrate-binding protein
TonB system transport protein ExbD1
MSHA biogenesis protein MshK
putative multidrug resistance protein
flagellin
putative sodium-dependent transporter
flagellin
flagellar basal body rod modification protein
putative protein F-related protein
chemotaxis CheV
putative translocator protein PopD
putative type III secretion protein
type III secretion outer membrane pore, YscC/HrcC family
putative traA protein
putative translocator protein PopD
putative regulator in type III secretion
outer protein J
hypothetical protein
conserved hypothetical protein
hypothetical protein
SanA protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
gonadoliberin III-related protein
FOG ggdef domain
hypothetical protein
conserved hypothetical protein
hypothetical protein
conserved hypothetical protein
hypothetical protein
hypothetical protein
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VP0054
VP2624
VP1518
VP1516
VP2789
VC0038
VPA0324
VPA0206
VP1107
VPA0521
VP0474
VPA1337
VP1803
A79_5484
VC0464
VP2294
VP2951
A79_4762
VC0464
VP2793
VPA1276
VPA1655
A79_4578
VP2387
A79_0232
A79_5856
A79_3690

hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
conserved hypothetical protein
transcriptional regulator, LuxR family
putative SAM-dependent methyltransferase
GlpG protein
transcriptional regulator, AraC family
transcriptional regulator, LuxR family
cyclic AMP receptor protein
putative DNA-binding response regulator
putative FecB
methyltransferase
transcriptional regulator, DeoR family
heme receptor HupA
transcriptional regulator
transcriptional regulator

96
REFERENCES
1. T. Fujino et al., On the bacteriological examination of shirasu-food poisoning. Med. J.
Osaka Univ., 299 (1953).
2. S. W. Joseph, R. R. Colwell, J. B. Kaper, Vibrio parahaemolyticus and related halophilic
Vibrios. Crit. Rev. Microbiol. 10, 77 (1982).
3. Y. Miyamoto et al., In vitro hemolytic characteristic of Vibrio parahaemolyticus: its
close correlation with human pathogenicity. J. Bacteriol. 100, 1147 (1969).
4. T. Kaneko, R. R. Colwell, Ecology of Vibrio parahaemolyticus in Chesapeake Bay. J.
Bacteriol. 113, 24 (1973).
5. T. A. Dadisman, Jr., R. Nelson, J. R. Molenda, H. J. Garber, Vibrio parahaemolyticus
gastroenteritis in Maryland. I. Clinical and epidemiologic aspects. Am. J.
Epidemiol. 96, 414 (1972).
6. J. R. Bonner, A. S. Coker, C. R. Berryman, H. M. Pollock, Spectrum of Vibrio
infections in a Gulf Coast community. Ann. Intern. Med. 99, 464 (1983).
7. C. N. Johnson et al., Relationships between environmental factors and pathogenic
vibrios in the northern Gulf of Mexico. Appl. Environ. Microbiol., (2009).
8. A. DePaola, L. H. Hopkins, J. T. Peeler, B. Wentz, R. M. McPhearson, Incidence of
Vibrio parahaemolyticus in U.S. coastal waters and oysters. Appl. Environ.
Microbiol. 56, 2299 (1990).
9. J. W. Davis, R. K. Sizemore, Incidence of Vibrio species associated with blue crabs
(Callinectes sapidus) collected from Galveston Bay, Texas. Appl. Environ.
Microbiol. 43, 1092 (1982).
10. R. K. Sizemore, R. R. Colwell, H. S. Tubiash, T. E. Lovelace, Bacterial flora of the
hemolymph of the blue crab, Callinectes sapidus: numerical taxonomy. Appl.
Microbiol.29, 393 (1975).
11. C. Vanderzant, R. Nickelson, Survival of Vibrio parahaemolyticus in shrimp tissue
under various environmental conditions. Appl. Microbiol.23, 34 (1972).
12. T. Kaneko, R. R. Colwell, Adsorption of Vibrio parahaemolyticus onto chitin and
copepods. Appl. Microbiol.29, 269 (1975).
13. U.S. Department of Health and Human Sevices, Quantitative Risk Assessment on the
Public Health Impact of Pathogenic Vibrio parahaemolyticus in Raw Oysters; Risk
Assessment. (Federal Register 2005, vol. 70, pp. 41772-41773).
14. N. A. Daniels et al., Vibrio parahaemolyticus infections in the United States, 19731998. J. Infect. Dis. 181, 1661 (2000).

97
15. N. A. Daniels et al., Emergence of a new Vibrio parahaemolyticus serotype in raw
oysters: A prevention quandary. J.A.M.A. 284, 1541 (2000).
16. U.S. Center for Disease Control, Outbreak of Vibrio parahaemolyticus infections
associated with eating raw oysters--Pacific Northwest, (M.M.W.R. 1997, 00987484).
17. U.S. Center for Disease Control, Outbreak of Vibrio parahaemolyticus infection
associated with eating raw oysters and clams harvested from Long Island Sound-Connecticut, New Jersey, and New York, 1998, (M.M.W.R., 1999, 0098-7484).
18. A. Chowdhury et al., Emergence and serovar transition of Vibrio parahaemolyticus
pandemic strains isolated during a diarrhea outbreak in Vietnam between 1997 and
1999. Microbiol. Immunol. 48, 319 (2004).
19. K. Garcia et al., Dynamics of clinical and environmental Vibrio parahaemolyticus
strains during seafood-related summer diarrhea outbreaks in southern Chile. Appl.
Environ. Microbiol. 75, 7482 (2009).
20. U.S. Center for Diease Control, Disease, Control, And, Prevention, (M.M.W.R , 2006,
55, 1-42).
21. V. Vuddhakul et al., Isolation of a pandemic O3:K6 clone of a Vibrio
parahaemolyticus strain from environmental and clinical sources in Thailand. Appl.
Environ. Microbiol. 66, 2685 (2000).
22. U.S. Center for Diease Control, Vibrio parahaemolyticus infections associated with
consumption of raw shellfish--three states, 2006, (M.M.W.R 2006, 55, 854).
23. K. Makino et al., Genome sequence of Vibrio parahaemolyticus: a pathogenic
mechanism distinct from that of V cholerae. Lancet 361, 743 (2003).
24. J. Martinez-Urtaza et al., Characterization of pathogenic Vibrio parahaemolyticus
isolates from clinical sources in Spain and comparison with Asian and North
American pandemic isolates. J. Clin. Microbiol. 42, 4672 (2004).
25. J. Martinez-Urtaza et al., Environmental determinants of the occurrence and
distribution of Vibrio parahaemolyticus in the rias of Galicia, Spain. Appl. Environ.
Microbiol. 74, 265 (2008).
26. Y. Miyamoto et al., Simplified purification and biophysicochemical characteristics of
Kanagawa phenomenon-associated hemolysin of Vibrio parahaemolyticus. Infect.
Immun. 28, 567 (1980).
27. T. Honda, Y. X. Ni, T. Miwatani, Purification and characterization of a hemolysin
produced by a clinical isolate of Kanagawa phenomenon-negative Vibrio
parahaemolyticus and related to the thermostable direct hemolysin. Infect. Immun.
56, 961 (1988).

98

28. J. Okuda, M. Ishibashi, S. L. Abbott, J. M. Janda, M. Nishibuchi, Analysis of the
thermostable direct hemolysin (tdh) gene and the tdh-related hemolysin (trh) genes
in urease-positive strains of Vibrio parahaemolyticus isolated on the West Coast of
the United States. J. Clin. Microbiol. 35, 1965 (1997).
29. H. Shirai et al., Molecular epidemiologic evidence for association of thermostable
direct hemolysin (TDH) and TDH-related hemolysin of Vibrio parahaemolyticus
with gastroenteritis. Infect. Immun. 58, 3568 (1990).
30. M. Nishibuchi, M. Ishibashi, Y. Takeda, J. B. Kaper, Detection of the thermostable
direct hemolysin gene and related DNA sequences in Vibrio parahaemolyticus and
other vibrio species by the DNA colony hybridization test. Infect. Immun. 49, 481
(1985).
31. C. N. Johnson et al., Genetic relatedness among tdh+ and trh+ Vibrio parahaemolyticus
cultured from Gulf of Mexico oysters (Crassostrea virginica) and surrounding
water and sediment. Microb. Ecol. 57, 437 (2009).
32. J. Okuda et al., Emergence of a unique O3:K6 clone of Vibrio parahaemolyticus in
Calcutta, India, and isolation of strains from the same clonal group from Southeast
Asian travelers arriving in Japan. J. Clin. Microbiol. 35, 3150 (1997).
33. V. Laohaprertthisan et al., Prevalence and serodiversity of the pandemic clone among
the clinical strains of Vibrio parahaemolyticus isolated in southern Thailand.
Epidemiol. Infect. 130, 395 (2003).
34. C. E. Meador et al., Virulence gene- and pandemic group-specific marker profiling of
clinical Vibrio parahaemolyticus isolates. J. Clin. Microbiol. 45, 1133 (2007).
35. T. Lynch et al., Vibrio parahaemolyticus disruption of epithelial cell tight junctions
occurs independently of toxin production. Infect. Immun. 73, 1275 (2005).
36. K. S. Park et al., Cytotoxicity and enterotoxicity of the thermostable direct hemolysindeletion mutants of Vibrio parahaemolyticus. Microbiol. Immunol. 48, 313 (2004).
37. R. N. Bhattacharjee et al., Microarray analysis identifies apoptosis regulatory gene
expression in HCT116 cells infected with thermostable direct hemolysin-deletion
mutant of Vibrio parahaemolyticus. Biochem. Biophys. Res. Commun. 335, 328
(2005).
38. K. Hoashi et al., Pathogenesis of Vibrio parahaemolyticus: intraperitoneal and
orogastric challenge experiments in mice. Microbiol. Immunol. 34, 355 (1990).
39. E. Arakawa et al., Emergence and prevalence of a novel Vibrio parahaemolyticus
O3:K6 clone in Japan. Jpn. J. Infect. Dis. 52, 246 (1999).

99
40. S. L. Abbott et al., Emergence of a restricted bioserovar of Vibrio parahaemolyticus as
the predominant cause of Vibrio-associated gastroenteritis on the West Coast of the
United States and Mexico. J. Clin. Microbiol. 27, 2891 (1989).
41. C. Matsumoto et al., Pandemic spread of an O3:K6 clone of Vibrio parahaemolyticus
and emergence of related strains evidenced by arbitrarily primed PCR and toxRS
sequence analyses. J. Clin. Microbiol. 38, 578 (2000).
42. P. K. Bag et al., Clonal diversity among recently emerged strains of Vibrio
parahaemolyticus O3:K6 associated with pandemic spread. J. Clin. Microbiol. 37,
2354 (1999).
43. N. R. Chowdhury et al., Clonal dissemination of Vibrio parahaemolyticus displaying
similar DNA fingerprint but belonging to two different serovars (O3:K6 and
O4:K68) in Thailand and India. Epidemiol. Infect. 125, 17 (2000).
44. N. R. Chowdhury et al., Molecular evidence of clonal Vibrio parahaemolyticus
pandemic strains. Emerg. Infect. Dis. 6, 631 (2000).
45. M. Okura et al., Genetic analyses of the putative O and K antigen gene clusters of
pandemic Vibrio parahaemolyticus. Microbiol. Immunol. 52, 251 (2008).
46. M. Okura et al., PCR-based identification of pandemic group Vibrio parahaemolyticus
with a novel group-specific primer pair. Microbiol. Immunol. 48, 787 (2004).
47. M. Okura et al., Genotypic analyses of Vibrio parahaemolyticus and development of a
pandemic group-specific multiplex PCR assay. J. Clin. Microbiol. 41, 4676 (2003).
48. Z. Lin, K. Kumagai, K. Baba, J. J. Mekalanos, M. Nishibuchi, Vibrio parahaemolyticus
has a homolog of the Vibrio cholerae toxRS operon that mediates environmentally
induced regulation of the thermostable direct hemolysin gene. J. Bacteriol. 175,
3844 (1993).
49. E. S. Krukonis, R. R. Yu, V. J. Dirita, The Vibrio cholerae ToxR/TcpP/ToxT virulence
cascade: distinct roles for two membrane-localized transcriptional activators on a
single promoter. Mol. Microbiol. 38, 67 (2000).
50. S. E. Lee et al., Vibrio vulnificus has the transmembrane transcription activator ToxRS
stimulating the expression of the hemolysin gene vvhA. J. Bacteriol. 182, 3405
(2000).
51. C. J. Hueck, Type III protein secretion systems in bacterial pathogens of animals and
plants. Microbiol. Mol. Biol. Rev. 62, 379 (1998).
52. G. R. Cornelis, F. Van Gijsegem, Assembly and function of type III secretory systems.
Annu. Rev. Microbiol. 54, 735 (2000).

100
53. P. Troisfontaines, G. R. Cornelis, Type III secretion: more systems than you think.
Physiology. 20, 326 (2005).
54. K. S. Park et al., Functional characterization of two type III secretion systems of Vibrio
parahaemolyticus. Infect. Immun. 72, 6659 (2004).
55. K. Izutsu et al., Comparative genomic analysis using microarray demonstrates a strong
correlation between the presence of the 80-kilobase pathogenicity island and
pathogenicity in Kanagawa phenomenon-positive Vibrio parahaemolyticus strains.
Infect. Immun. 76, 1016 (2008).
56. T. Sugiyama, T. Iida, K. Izutsu, K. S. Park, T. Honda, Precise region and the character
of the pathogenicity island in clinical Vibrio parahaemolyticus strains. J. Bacteriol.
190, 1835 (2008).
57. T. Iida et al., Close proximity of the tdh, trh and ure genes on the chromosome of
Vibrio parahaemolyticus. Microbiology 144, 2517 (1998).
58. N. Okada et al., Identification and characterization of a novel type III secretion system
in trh-positive Vibrio parahaemolyticus strain TH3996 reveal genetic lineage and
diversity of pathogenic machinery beyond the species level. Infect. Immun. 77, 904
(2009).
59. N. F. Noriea, 3rd, C. N. Johnson, K. J. Griffitt, D. J. Grimes, Distribution of type III
secretion systems in Vibrio parahaemolyticus from the northern Gulf of Mexico. J
Appl. Microbiol.109, 953 (2010).
60. T. Ono, K. S. Park, M. Ueta, T. Iida, T. Honda, Identification of proteins secreted via
Vibrio parahaemolyticus type III secretion system 1. Infect. Immun. 74, 1032
(2006).
61. T. Kodama et al., Identification of two translocon proteins of Vibrio parahaemolyticus
type III secretion system 2. Infect. Immun. 76, 4282 (2008).
62. T. Kodama et al., Identification and characterization of VopT, a novel ADPribosyltransferase effector protein secreted via the Vibrio parahaemolyticus type III
secretion system 2. Cell. Microbiol. 9, 2598 (2007).
63. Y. Akeda et al., Identification and characterization of a type III secretion-associated
chaperone in the type III secretion system 1 of Vibrio parahaemolyticus. FEMS
Microbiol. Lett. 296, 18 (2009).
64. I. Adkins, S. Schulz, S. Borgmann, I. B. Autenrieth, S. Grobner, Differential roles of
Yersinia outer protein P-mediated inhibition of nuclear factor-kappa B in the
induction of cell death in dendritic cells and macrophages. J. Med. Microbiol. 57,
139 (2008).

101
65. A. D. Liverman et al., Arp2/3-independent assembly of actin by Vibrio type III effector
VopL. Proc. Natl. Acad. Sci. U.S.A. 104, 17117 (2007).
66. M. D. Gamble, C. R. Lovell, Infaunal burrows are enrichment zones for Vibrio
parahaemolyticus. Appl. Environ. Microbiol. 77, 3703 (2011).
67. D. J. Grimes et al., What genomic sequence information has revealed about Vibrio
ecology in the ocean--a review. Microb. Ecol. 58, 447 (2009).
68. A. M. Zimmerman et al., Variability of total and pathogenic Vibrio parahaemolyticus
densities in northern Gulf of Mexico water and oysters. Appl. Environ. Microbiol.
73, 7589 (2007).
69. A. K. Bej et al., Detection of total and hemolysin-producing Vibrio parahaemolyticus
in shellfish using multiplex PCR amplification of tl, tdh and trh. J. Microbiol.
Methods. 36, 215 (1999).
70. K. Zwirglmaier, W. Ludwig, K. H. Schleifer, Recognition of individual genes in a
single bacterial cell by fluorescence in situ hybridization--RING-FISH. Mol.
Microbiol. 51, 89 (2004).
71. M. Stoffels, W. Ludwig, K. H. Schleifer, rRNA probe-based cell fishing of bacteria.
Environ. Microbiol. 1, 259 (1999).
72. A. DePaola, C. A. Kaysner, J. Bowers, D. W. Cook, Environmental investigations of
Vibrio parahaemolyticus in oysters after outbreaks in Washington, Texas, and New
York (1997 and 1998). Appl. Environ. Microbiol. 66, 4649 (2000).
73. A. DePaola, J. L. Nordstrom, J. C. Bowers, J. G. Wells, D. W. Cook, Seasonal
abundance of total and pathogenic Vibrio parahaemolyticus in Alabama oysters.
Appl. Environ. Microbiol. 69, 1521 (2003).
74. N. Nakasone, M. Iwanaga, The role of pili in colonization of the rabbit intestine by
Vibrio parahaemolyticus Na2. Microbiol. Immunol. 36, 123 (1992).
75. M. Nishibuchi, J. Kaper, Thermostable Direct Hemolysin Gene of Vibrio
parahaemolyticus: a Virulence gene Aquired by a marine bacterium. Infection and
Immunity 63, 2093 (1995).
76. T. M. Minton, A Review of the Market Structure of the Louisiana Oyster Industry: A
Microcosm of the United States Oyster Industry. Journal of Shellfish Research
(2004).
77. N. R. Chowdhury, O. C. Stine, J. G. Morris, G. B. Nair, Assessment of evolution of
pandemic Vibrio parahaemolyticus by multilocus sequence typing. J. Clin.
Microbiol. 42, 1280 (2004).

102
78. G. Caburlotto, M. Gennari, V. Ghidini, M. Tafi, M. M. Lleo, Presence of T3SS2 and
other virulence-related genes in tdh-negative Vibrio parahaemolyticus
environmental strains isolated from marine samples in the area of the Venetian
Lagoon, Italy. FEMS Microbiol. Ecol. 70, 506 (2009).
79. T. Kodama, [Functional analysis of type III secretion system 2 of Vibrio
parahaemolyticus]. Nihon saikingaku zasshi. Japanese Journal of Bacteriology 64,
303 (2009).
80. T. Kodama et al., Two regulators of Vibrio parahaemolyticus play important roles in
enterotoxicity by controlling the expression of genes in the Vp-PAI region. PLoS
One 5 (2010).
81. S. M. Allen, L. E. Burnett, The effects of intertidal air exposure on the respiratory
physiology and the killing activity of hemocytes in the pacific oyster, Crassostrea
gigas (Thunberg). Journal of Experimental Marine Biology and Ecology, 165
(2008).
82. F. J. Genthner, A. K. Volety, L. M. Oliver, W. S. Fisher, Factors influencing in vitro
killing of bacteria by hemocytes of the eastern oyster (Crassostrea virginica). Appl.
Environ. Microbiol. 65, 3015 (1999).
83. G. Caburlotto et al., Effect on human cells of environmental Vibrio parahaemolyticus
strains carrying type III secretion system 2. Infect. Immun. 78, 3280 (2010).
84. F. Raimondi et al., Enterotoxicity and cytotoxicity of Vibrio parahaemolyticus
thermostable direct hemolysin in in vitro systems. Infect. Immun. 68, 3180 (2000).
85. A. K. Volety, L. M. Oliver, F. J. Genthner, W. S. Fisher, A rapid tetrazolium dye
reduction assay to assess the bactericidal activity of oyster (Crassostrea virginica)
hemocytes against Vibrio parahaemolyticus. Aquaculture 172, 18 (1999).
86. A. K. Volety et al., Responses of oyster Crassostrea virginica hemocytes to
environmental and clinical isolates of Vibrio parahaemolyticus. Aquatic Microbial
Ecology 25, 10 (2001).
87. L. Harris-Young, M. L. Tamplin, J. W. Mason, H. C. Aldrich, J. K. Jackson, Viability
of Vibrio vulnificus in Association with Hemocytes of the American Oyster
(Crassostrea virginica). Appl. Environ. Microbiol. 61, 52 (1995).
88. S. Yoshida, M. Ogawa, Y. Mizuguchi, Relation of capsular materials and colony
opacity to virulence of Vibrio vulnificus. Infect. Immun. 47, 446 (1985).
89.

L. Smetanova, V. Stetinova, Z. Svoboda, J. Kvetina, Caco-2 Cells,
Biopharmaceutics Classification System (BCS) and Biowaiver. Acta Medica 54, 6
(2011).

103
90. A. Takahashi, T. Iida, R. Naim, Y. Naykaya, T. Honda, Chloride secretion induced by
thermostable direct haemolysin of Vibrio parahaemolyticus depends on colonic cell
maturation. J. Med. Microbiol. 50, 870 (2001).
91. A. Takahashi, N. Kenjyo, K. Imura, Y. Myonsun, T. Honda, Cl(-) secretion in colonic
epithelial cells induced by the vibrio parahaemolyticus hemolytic toxin related to
thermostable direct hemolysin. Infect. Immun. 68, 5435 (Sep, 2000).
92. A. Takahashi et al., Haemolysin produced by Vibrio mimicus activates two Clsecretory pathways in cultured intestinal-like Caco-2 cells. Cell Microbiology 9,
583 (2007).
93. M. Heyman, A. M. Crain-Denoyelle, S. K. Nath, J. F. Desjeux, Quantification of
protein transcytosis in the human colon carcinoma cell line CaCo-2. Journal of
Cellular Physiology 143, 391 (1990).
94. X. Zhou, M. E. Konkel, D. R. Call, Regulation of type III secretion system 1 gene
expression in Vibrio parahaemolyticus is dependent on interactions between ExsA,
ExsC, and ExsD. Virulence 1, 260 (2010).
95. X. Zhou, D. H. Shah, M. E. Konkel, D. R. Call, Type III secretion system 1 genes in
Vibrio parahaemolyticus are positively regulated by ExsA and negatively regulated
by ExsD. Mol. Microbiol. 69, 747 (2008).
96. L. McCarter, Dual Flagellar Systems Enable Motility under Different Circumstances.
Molecular Microbiology and Biotechnology, 18 (2004).
97. L. McCarter, M. Hilmen, M. Silverman, Flagellar dynamometer controls swarmer cell
differentiation of V. parahaemolyticus. Cell 54, 345 (1988).
98. L. McCarter, M. Silverman, Surface-induced swarmer cell differentiation of Vibrio
parahaemolyticus. Mol. Microbiol. 4, 1057 (1990).
99. L. L. McCarter, M. E. Wright, Identification of genes encoding components of the
swarmer cell flagellar motor and propeller and a sigma factor controlling
differentiation of Vibrio parahaemolyticus. J. Bacteriol. 175, 3361 (1993).
100. J. M. Henke, B. L. Bassler, Quorum sensing regulates type III secretion in Vibrio
harveyi and Vibrio parahaemolyticus. J. Bacteriol. 186, 3794 (2004).
101. F. Raimondi, J. P. Kao, J. B. Kaper, S. Guandalini, A. Fasano, Calcium-dependent
intestinal chloride secretion by Vibrio parahaemolyticus thermostable direct
hemolysin in a rabbit model. Gastroenterology 109, 381 (1995).
102. F. B. Abdallah, A. Bakhrouf, A. Ayed, H. Kallel, Alterations of Outer Membrane
Proteins and Virulence Genes Expression in Gamma-Irradiated Vibrio
parahaemolyticus and Vibrio alginolyticus. Foodborne. Pathog. Dis., (2009).

104
103. M. L. Chiang, C. C. Chou, Expression of superoxide dismutase, catalase and
thermostable direct hemolysin by, and growth in the presence of various nitrogen
and carbon sources of heat-shocked and ethanol-shocked Vibrio parahaemolyticus.
Int. J. Food Microbiology 121, 268 (2008).
104. S. W. Chiu, S. Y. Chen, H. C. Wong, Localization and expression of MreB in Vibrio
parahaemolyticus under different stresses. Appl. Environ. Microbiol. 74, 7016
(2008).
105. F. Coutard, S. Lozach, M. Pommepuy, D. Hervio-Heath, Real-time reverse
transcription-PCR for transcriptional expression analysis of virulence and
housekeeping genes in viable but nonculturable Vibrio parahaemolyticus after
recovery of culturability. Appl. Environ. Microbiol. 73, 5183 (2007).
106. C. J. Gode-Potratz, R. J. Kustusch, P. J. Breheny, D. S. Weiss, L. L. McCarter,
Surface sensing in Vibrio parahaemolyticus triggers a programme of gene
expression that promotes colonization and virulence. Mol. Microbiol. 79, 240
(2011).
107. Z. Mao, L. Yu, Z. You, Y. Wei, Y. Liu, Cloning, expression and immunogenicty
analysis of five outer membrane proteins of Vibrio parahaemolyticus zj2003. Fish
Shellfish Immunology 23, 567 (2007).
108. L. L. McCarter, M. Silverman, Phosphate regulation of gene expression in Vibrio
parahaemolyticus. J. Bacteriol. 169, 3441 (1987).
109. L. Yang et al., Cold-induced gene expression profiles of Vibrio parahaemolyticus: a
time-course analysis. FEMS Microbiol. Lett. 291, 50 (2009).
110. F. L. Thompson, A. A. Neto, O. Santos Ede, K. Izutsu, T. Iida, Effect of N-acetyl-Dglucosamine on gene expression in Vibrio parahaemolyticus. Microbes and
environments 26, 61 (2011).
111. D. Wang, S. Yu, W. Chen, D. Zhang, X. Shi, Enumeration of Vibrio
parahaemolyticus in oyster tissues following artificial contamination and
depuration. Lett Appl. Microbiol.51, 104 (2010).
112. M. J. Chae, D. Cheney, Y. C. Su, Temperature effects on the depuration of Vibrio
parahaemolyticus and Vibrio vulnificus from the American oyster (Crassostrea
virginica). J. Food. Sci. 74, M62 (2009).
113. L. Croci, E. Suffredini, L. Cozzi, L. Toti, Effects of depuration of molluscs
experimentally contaminated with Escherichia coli, Vibrio cholerae 01 and Vibrio
parahaemolyticus. J Appl. Microbiol.92, 460 (2002).
114.

A. Richardson, S. Fedoroff, Protocols for Neural Cell Culture 3rd Edition.
(Humana Press, NJ, 1997).

105
115. Y. Gueguen et al., Immune gene discovery by expressed sequence tags generated
from hemocytes of the bacteria-challenged oyster, Crassostrea gigas. Gene 303,
139 (2003).
116. H. Li, M. G. Parisi, M. Toubiana, M. Cammarata, P. Roch, Lysozyme gene
expression and hemocyte behaviour in the Mediterranean mussel, Mytilus
galloprovincialis, after injection of various bacteria or temperature stresses. Fish
Shellfish Immunology 25, 143 (2008).
117. D. A. Foley, T. C. Cheng, A quantitative study of phagocytosis by hemolymph cells
of the pelecypods Crassostrea virginica and Mercenaria mercenaria. J. Invertebr.
Pathol. 25, 189 (1975).
118. K. Terahara et al., Differences in integrin-dependent phagocytosis among three
hemocyte subpopulations of the Pacific oyster "Crassostrea gigas". Dev. Comp.
Immunol. 30, 667 (2006).
119. C. Cellura, M. Toubiana, N. Parrinello, P. Roch, Specific expression of antimicrobial
peptide and HSP70 genes in response to heat-shock and several bacterial challenges
in mussels. Fish Shellfish Immunology 22, 340 (2007).
120. Y. Akeda et al., Dominant-negative Rho, Rac, and Cdc42 facilitate the invasion
process of Vibrio parahaemolyticus into Caco-2 cells. Infect. Immun. 70, 970
(2002).
121. Y. Akeda et al., Identification of the Vibrio parahaemolyticus type III secretion
system 2-associated chaperone VocC for the T3SS2-specific effector VopC. FEMS
Microbiol. Lett. 324, 156 (2011).
122. Y. Akeda, K. Nagayama, K. Yamamoto, T. Honda, Invasive phenotype of Vibrio
parahaemolyticus. J. Infect. Dis. 176, 822 (1997).
123. A. Alam, K. A. Miller, M. Chaand, J. S. Butler, M. Dziejman, Identification of Vibrio
cholerae type III secretion system effector proteins. Infect. Immun. 79, 1728 (2011).
124. R. N. Bhattacharjee et al., Translocation of VP1686 upregulates RhoB and accelerates
phagocytic activity of macrophage through actin remodeling. J Microbiol.
Biotechnol. 18, 171 (2008).
125. X. Lian et al., Vibrio parahaemolyticus elevates interferon alpha production in
intestinal-like epithelial Caco-2 cells. Can. J. Microbiol. 53, 1084 (2007).
126. T. Shimohata et al., Vibrio parahaemolyticus infection induces modulation of IL-8
secretion through dual pathway via VP1680 in Caco-2 cells. J. Infect. Dis. 203, 537
(2011).
127. T. Tsuchiya, S. Shinoda, Respiration-driven Na+ pump and Na+ circulation in Vibrio
parahaemolyticus. J. Bacteriol. 162, 794 (1985).

106

128. J. V. Holtje, D. Mirelman, N. Sharon, U. Schwarz, Novel type of murein
transglycosylase in Escherichia coli. J. Bacteriol. 124, 1067 (1975).
129. T. Tanabe et al., Identification and characterization of genes required for biosynthesis
and transport of the siderophore vibrioferrin in Vibrio parahaemolyticus. J.
Bacteriol. 185, 6938 (2003).
130. C. N. Peterson, M. J. Mandel, T. J. Silhavy, Escherichia coli starvation diets: essential
nutrients weigh in distinctly. J. Bacteriol. 187, 7549 (2005).
131. F. C. Fang et al., The alternative sigma factor katF (rpoS) regulates Salmonella
virulence. Proc. Natl. Acad. Sci. U.S.A. 89, 11978 (1992).
132. R. Lange, R. Hengge-Aronis, Identification of a central regulator of stationary-phase
gene expression in Escherichia coli. Mol. Microbiol. 5, 49 (1991).
133. T. Atsumi, L. McCarter, Y. Imae, Polar and lateral flagellar motors of marine Vibrio
are driven by different ion-motive forces. Nature 355, 182 (1992).
134. C. Xu, H. Ren, S. Wang, X. Peng, Proteomic analysis of salt-sensitive outer
membrane proteins of Vibrio parahaemolyticus. Res Microbiol 155, 835 (2004).
135. K. Postle, R. J. Kadner, Touch and go: tying TonB to transport. Mol. Microbiol. 49,
869 (2003).
136. C. J. Gode-Potratz, D. M. Chodur, L. L. McCarter, Calcium and iron regulate
swarming and type III secretion in Vibrio parahaemolyticus. J. Bacteriol. 192, 6025
(2010).
137. C. J. Gode-Potratz, L. L. McCarter, Quorum sensing and silencing in Vibrio
parahaemolyticus. J. Bacteriol. 193, 4224 (2011).
138. V. Sperandio, J. L. Mellies, W. Nguyen, S. Shin, J. B. Kaper, Quorum sensing
controls expression of the type III secretion gene transcription and protein secretion
in enterohemorrhagic and enteropathogenic Escherichia coli. Proc. Natl. Acad. Sci.
U.S.A. 96, 15196 (1999).
139. J. L. Nordstrom, M. C. Vickery, G. M. Blackstone, S. L. Murray, A. DePaola,
Development of a multiplex real-time PCR assay with an internal amplification
control for the detection of total and pathogenic Vibrio parahaemolyticus bacteria
in oysters. Appl. Environ. Microbiol. 73, 5840 (2007).

